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The neuromodulatory role of tumor necrosis factor-a (TNF) on 
taurine transport and other metabolic processes on rat cortical cultured 
astrocytes were examined. Cells grown in serum-free (SF), serum-containing 
(S) and serum plus dbcAMP (SC) media were also examined in order to 
compare the changes under different maturation states. 
Taurine uptake in rat astrocytes was a saturable and time-dependent 
process and its uptake in cells grown in different media varied, highest 
being in those cells grown in SF medium. TNF stimulated taurine uptake in 
rat astrocytes (pltured in all toee media and this effect was time- and dose-
dependent. Kinetic studies showed that TNF stimulated taurine uptake by 
decreasing the K^ values of the transporters for taurine and increasing the 
Vmax values. TNF also inhibited the rate of taurine release slightly. The 
effect of TNF on taurine uptake appears to be species-specific as its effects 
\ 
on primary mouse astrocytes and C6 glioma cells differed from that on rat 
astrocytes. 
Lipopolysaccharide which is known to induce TNF secretion from 
astrocytes also stimulated taurine transport via a manner similar to that of 
TNF. Interferon-T, a cytokine which is secreted by lymphocytes significantly 
、 . 
reduced taurine uptake, and this inhibition was reversed by the addition of 
TNF. It seems that the effect of TNF on taurine uptake in rat astrocytes is 
cytokine-specific. 
TNF inhibited the uptake of glutamate, tyrosine, GAB A and glucose 
with various degrees, while the uptake of NE, DA and leucine were 
unaffected. This finding suggests that the effect of TNF on taurine uptake 
is substrate-specific and that TNF did not affect taurine transport by 
interfering Na+ movement across the astrocytic plasma membrane. Neither 
did TNF exert its effect through protein kinase C (PKC) as phorbol-12 
myristate-13-acetate, a PKC activator, decreased rather than increased 
taurine uptake. 
Apart from its effect on taurine transport, TNF stimulated DNA and 
RNA synthesis in rat astrocytes, while protein synthesis was unaffected. In 
addition, TNF increased cGMP production in matured rat astrocytes and its 
effect on matured and differentiated astrocytes was dose-dependent. Lastly, 
it stimulated protein phosphorylation in cells cultured in the SC medium, but 
inhibited phosphorylation in cells grown in the S medium. 
In conclusion, this study revealed that the effect of TNF on taurine 
transport in cultured rat cortical astrocytes is substrate-, species- and perhaps 
cytokine-specific. Astrocytic swelling is a strategy to rescue neurons from 
further damage in brain injuries and that TNF is one of the important 
、 . 
cytokines secreted to modulate central immune responses in pathological 
conditions. The present finding showed that TNF affects the transport of 
taurine, an important central osmolyte, suggesting that the regulation of 
taurine transport by TNF may play an important functional role in brain 
injuries and neuropathological conditions. 
、 . 
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CHAPTER I INTRODUCTION 
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1.1 Astrocytes in the Central Nervous System 
1.1.1 Characteristics of astrocytes 
Rudolf Virchow, a great German pathologist, first used the term 
"neuroglia" in 1846 to describe a glue-like region between neurons. We 
now know that this glue-like material, neuroglia, is further classified as 
macroglia and microglia in the central nervous system (CNS). Astrocytes are 
the major constituents of macroglia. Microglia and oligodendrocytes are 
relatively the minor constituents of neuroglia. 
Astrocytes are the most abundant cell type in the CNS�The ratio of 
astrocytes to neurons is about 10:1. They are derived from the 
neuroectoderm of the neural tube. Morphologically, astrocytes can be 
classified into two types: protoplasmic and fibrous. Protoplasmic astrocytes 
are characterised by thick, branched processes with spiny projections and are 
mainly localized in the grey matter. In contrast, the fibrous astrocytes have 
relatively bony and thin processes with few branches and are primarily 
localized in the white matter (Guroff, 1980). 
Apart from having distinct morphology and distribution, astrocytes 
also contain characteristic biochemical markers. Firstly, astrocytes can be 
characterised by having glial fibrillary acidic protein (GFAP), the subunits 
、 . 
of glial-specific intermediate filaments. As a result, GFAP is commonly 
used as an astrocyte marker for both in vivo and in vitro studies (Eng et al., 
1971; Uyeda et al., 1972; Dahl and Bignami, 1973; Yen and Fields, 1981). 
Another marker for astrocytes is the S-100 protein, which is a type of small, 
highly acidic and water-soluble protein (Ghandour et al., 1981a, b), and is 
considered to be structurally related to calcium binding protein. Thirdly, 
glutamine synthetase (GS) (Norenberg, 1979)，an enzyme catalyzing the 
amidation of glutamate to glutamine, could also be used as an astrocyte 
marker since astrocytes could store glutamine in the CNS. However, the 
specificity of GS is not as high as GFAP because oligodendrocytes also 
contains GS (Martinez-Hernandez et al., 1977). 
1.1.2 Functional roles of astrocytes 
1.1.2.1 General functions of astrocytes 
Astrocytes had in the past been only given the role of supportive cells 
in the CNS. Increasing evidence have now shown that astrocytes do play 
key roles in the normal functions of the CNS. Firstly, astrocytes secrete 
trophic factors, such as nerve growth factor (NGF) necessary for neuronal 
development and survival (Manthorpe et al., 1986). Secondly, they also give 
guidance for migrating neurons during development (Rakic et al., 1971a, b). 
Also, astrocytes control the extracellular ionic environment by functioning 
、 . 
as potassium spatial buffering cells (Paulson and Newman, 1987) as well as 
compartmentalization for GABA and glutamate (Hertz and Schousboe, 
1986). They also participate in the formation of the node of Ranvier 
(Ffrench-Constant et al., 1986) and in the induction of the blood-brain-
barrier properties in the endothelial cells in the CNS (Janzer and Raff, 
1987). 
In cerebral ischemia or hypoglycaemia, astrocytic swelling is 
considered to be an early response to injury (Garcia and Lossinsky, 1979; 
Jenkins et al., 1984). The swelling of astrocytes may be a strategy in 
rescuing neurons during CNS injury. Since cell swelling is related to its 
volume change, how astrocytes control cell volume is an important subject 
in studying the functional roles of astrocytes in the CNS. 
1.1.2.2 Volume regulation of astrocytes in CNS injuries 
It is known that astrocytes play an important role in osmoregulatory 
functions and cellular volume control in the CNS (Pasantes-Morales and 
Schousboe, 1990; Huxtable, 1992). In a number of pathological states, such 
as head injuries, ischemia, epilepsy and hepatic encephalopathy, astrocytic 
swelling is an early event in the brain (Kimelberg and Ransom, 1986). 
Astrocytic swelling may be a strategy to save neuronal cells because they 
are very vulnerable to osmolality and cell volume changes. 
、 . 
Most of our knowledge on astrocytic swelling came from the study 
of primary astrocyte cultures exposed to various osmotic media. Astrocytes 
exposed to hypotonic medium resulted in cellular swelling. Astrocytes will 
subsequently restore their cell volume towards normal size even in the 
presence of the hypotonic medium, this process is termed regulatory volume 
decrease (RVD) (Hoffmann, 1987). During RVD, volume adjustment is 
accomplished by the secretion of mobilizing intracellular free amino acids 
and active osmotic solutes, such as potassium and chloride (Pasantes-
Morales and Schousboe, 1989，1990). Among the secreted free amino acids, 
taurine is one of the most abundant (Pasantes-Morales and Schousboe, 1988; 
Kimelberg et al.，1990a) and it has been shown that taurine has a mild 
inhibitory effect on neurons. Secretion of taurine contributes not only to the 
adjustment of cell volume and osmolality, but also to the inhibition of 
neuronal excitability after exposure to glutamate and potassium. This may 
be the strategy of how astrocytes participate in the volume regulation in the 
brain. 
1.1.2.3 Immunological functions of astrocytes 
In addition to the change in cell volume and osmolality in astrocytes 
after brain injury, it had been shown that astrocytes also participate in 
immune responses in the CNS after brain injury (Berkenbosch, 1992). 
However, it is not clear whether factors associated with such immune 
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responses may regulate other cellular events in the astrocytes, and this part 
will be examined in this study. 
There is increasing evidence indicating that astrocytes can function 
as immunocompetent cells in the CNS. The first line of evidence came from 
the study by Wong and coworker in 1984 showing that astrocytes can 
express major histocompatibility complex (MHC) in class I and class II 
upon interferon-T (IFN-x) stimulation. Later, it was reported that certain 
viral infections (Massa et al.，1987; Rodriguez et al., 1987), soluble toxins, 
such as tetanus toxoid (Cusimano et al., 1989), and tumor necrosis factor 
(TNF) (Benveniste et al., 1989; Vidovic et al., 1990) could also induce 
MHC expression. Apart from MHC expression, intercellular adhesion 
molecules (ICAM)，which trigger and stabilize the interaction of 
lymphocytes and antigen-presenting cells, can also be expressed on 
astrocytes upon the stimulation by IFN-T, TNF-a and interleukin-1 (IL-1) 
(Frohman et al., 1989a, b; Satoh et al., 1991a, b). In addition, astrocytes 
were shown to have phagocytic activity to foreign antigens (Watabe et al.， 
1989). All these evidence showed that astrocytes can function as antigen-
presenting cells in the CNS. 
On the other hand, astrocytes can secrete a number of cytokines, such 
as IL-1, IL-3, IL-6, IL-8, colony stimulatory factor (CSF-1), tumor necrosis 
factor-a (TNF-a) and transforming growth factor (TGF-6) (Fontana et al., 
、 . 
1982; Frei et al., 1985; Wrann et al., 1987; Benveniste et al.，1990; Chung 
。 
and Benveniste, 1990; Hao et al., 1990; Kasahara et al., 1991). These 
cytokines can up-regulate or down-regulate immune responses in the brain. 
Since astrocytes can secrete a wide range of cytokines and can function as 
antigen-presenting cells, astrocytes have been considered to be one of the 
important cell types in modulating the immune response in the brain. 
However, under normal condition, astrocytes do not express such immune 
functions, as norepinephrine and vasoactive intestinal polypeptide presented 
in the brain had been shown to inhibit MHC class II expression in normal 
cultured astrocytes (Frohman et al., 1988a, b). This may imply that 
neurotransmitters or neurohormones can inhibit immune responses in the 
brain and also partly explain why the brain has been viewed as an 
immunopriviledged site for many years. 
It will therefore be of interest to further investigate the change in 
cellular events in astrocytes, such as volume control, resulting from the 
release of cytokines after brain injury. 
1.2 Taurine in the CNS 
1.2.1 The biochemistry and distribution of taurine 
Taurine, 2-aminoethane sulfonic acid (Fig. 1.1), is considered to be 
chemically inert, in the sense that most of the taurine are secreted without 
、 . 
being metabolized. The ultimate source of taurine came from sulphur-
containing amino acids, such as methionine and cysteine. Since mammals 
are capable only of sulphur oxidation, but not reduction, the biosynthesis of 
taurine undergoes through a series of sulphur oxidation processes. The 
biosynthetic pathways of taurine are shown in Fig. 1.2. Most of the cysteine 
sulfmate is produced in the liver by cysteine dioxygenase; cysteine sulfinate 
will be metabolized either to cysteate by cysteine sulfinate dehydrogenase 
or to hypotaurine by cysteine sulfinate decarboxylase. Cysteate is then 
metabolized into taurine by cysteine sulfinate decarboxylase, and 
hypotaurine is oxidized to taurine by hypotaurine dehydrogenase. 
In mammals, taurine has been found in high concentrations in the 
heart and in the brain (Huxtable, 1992). However, in all the regions 
examined, retina has a much higher concentration of taurine than other 
regions in the rest of the brain (Pasantes-Morales, 1986). In newborn 
mammals, the concentration of taurine is found to be especially high in the 
brain, and the level decreases during development (Sturman, 1993)�In 
contrast, the activity of cysteine sulfinate decarboxylase has been found to 
increase during development (Akahori et al., 1984, 1986). 
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Fig. 1.2 The biosynthesis of taurine from cysteine. Cysteine dioxygenase is mainly produced in liver, but not in the CNS. 
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1.2.2 Physiological functions of taurine in the CNS 
At present, there are many physiological roles postulated for taurine 
in the CNS. For example, taurine was postulated to function as an inhibitory 
neurotransmitter (Davison and Kazmarek, 1971; Oja and Konto, 1978). 
However, since the release of taurine is not a calcium-dependent mechanism 
like that of other neurotransmitters, therefore, taurine does not completely 
fulfil the criteria of neurotransmitters. 
Taurine was also reported to modulate many Ca^^-dependent 
processes. For example, taurine was shown to modulate GABA release in 
cerebellar slices of the guinea pig (Namima et al., 1983), to cause the 
increase in association of calcium with brain mitochondria (Nakagawa and 
Kuriyama, 1979)，and to modulate neurotransmitter release by affecting Ca� . 
accumulation in rat brain synaptosomes (Pasantes-Morales and Gamboa, 
1980). Apart from these roles, taurine was also considered to function in 
membrane protection especially in rod cells damaged by retinol (Pasantes-
Morales and Cruz, 1985). 
Taurine is metabolically inert, which is suggestive of its passive 
participation in cell metabolism and seldom incorporation into proteins. It 
is neutral in charge at physiological pH and therefore changes in taurine 
concentration would not drastically alter cell membrane potential, enzyme 
、 . 
activities or other cellular processes. Taurine is transported by a system 
unique to 6-amino acids, the transport is Na+-dependent and is responsive 
to ionic changes (Van Gelder, 1989). Furthermore, taurine exists in high 
concentrations in the CNS (Sturman, 1993). These unique properties of 
taurine render it an ideal osmoregulator in the brain (Huxtable, 1992). 
1.2.3 Uptake and release of taurine by cultured astrocytes 
Cultured astrocytes were found to have greater transport capacity for 
taurine than that of cultured neurons (Schousboe et al” 1976). In response 
to different ionic environments, such as (i) hyperosmolarity，(ii) 
hyposmolarity or (iii) isosmolarity but with high potassium, astrocytes were 
shown to take up or release taurine so as to modulate the cell volume and 
osmoregulation in the brain (Pasantes-Morales and Schousboe, 1988; 
Kimelberg et al.，1990a, b; Sanchez-Olea et al., 1992). 
Taurine in the CNS primarily comes from dietary sources and hepatic 
biosynthesis. The inherent synthetic capacity for this amino acid is low in 
the brain. In cultured astrocytes, the source of taurine may be derived from 
the serum in the culture medium (Wu, 1984). 
、 . 
1.2.3.1 Taurine uptake in astrocytes 
Hanretta and Lombardini (1986) through the studying of 
hypothalamic neuronal and glial cell particles showed that there are two 
uptake systems for taurine in the brain. Neuronal cells were found to have 
a high-affinity uptake system for taurine, whereas astrocytes were found to 
have a low-affinity uptake system. However, Schousboe and his coworkers 
(1976) demonstrated that the uptake capacity for taurine in astrocytes were 
higher than that in neurons. 
Taurine uptake is achieved primarily by a Na+-dependent process, 
with Na+ being cotransported into the cells (Oja and Kontro, 1983). The 
uptake of taurine is similar to that of GABA, with more than one sodium 
ion required per taurine molecule transported. 
The substrate specificity of this transport system is high, since only 
6-alanine was found to be a potent inhibitor of taurine uptake in astrocytes 
(Schousboe et al., 1976). 
Astrocytes in response to hyperosmotic medium will increase the 
intracellular concentration of free amino acids, especially taurine. Sanchez-
Olea and coworkers (1992) showed that hyperosmolarity caused an increase 
in taurine uptake and this process was not mediated by alternation of the 
affinity of the transporter for taurine, but mediated by stimulating the 
、 . 
turnover rate of the transporters. 
1.2.3.2 Taurine release in astrocytes 
Taurine taken up by astrocytes is stored in a free form in the cytosol. 
The increase in taurine release is the adaptive response of astrocytes to 
different osmotic environments, like hyposmolarity. It is well documented 
that astrocytes exposed to hypotonic medium or, isotonic medium but with 
high K+ concentration, will induce a rapid cell swelling. Following the 
swelling, astrocytes will restore their cell volume towards normal size, a 
process known called regulatory volume decrease (RVD). Taurine was 
released during the RVD (Pasantes-Morales and Schousboe, 1989, 1990). 
High external glutamate level and high incubation temperature were also 
found to increase taurine release from astrocytes (Dutton and Philibert, 
1990; Tigges et al.，1990). 
The increased taurine release from astrocytes in response to 
hyposmolarity or high K+ seems to involve two separate mechanisms. In 
hyposmotic medium, taurine release is not triggered by the reduction of cell 
swelling, but by the reduction of external osmolality. However, in high K+-
evoked taurine efflux, the release of taurine is proportionate to the degree 
of swelling rather than to the concentration of K+ (Pasantes-Morales and 
Schousboe, 1989). 
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Apart from the above characteristics, Dutton and Philibert (1990) also 
showed that taurine released from cerebellar astrocytes is mildly sensitive 
to extracellular Ca^ .^ Decreasing the extracellular Ca^^ to the level of 0 -
ImM will increase the basal release of taurine, but this increase was blocked 
by lOmM 
On the whole, the increase in taurine release from astrocytes 
symbolizes the existence of osmotic stress in the brain. Astrocytic swelling 
is a common early event in osmotic, neurotoxic and thermotic crisis. 
Following astrocytic swelling, taurine will be markedly released to 
extracellular environment to reduce osmotic stress. Taurine not only adjusts 
the osmolality of the extracellular fluid, but also inhibits the neurotoxic 
effects of released glutamate to neurons (Benveniste et al., 1984; Lehmann 
et al., 1984). Although taurine alone is not sufficient to restore osmotic 
equilibrium across the cell membrane, it seems to be an essential factor in 
the osmoregulation of the brain. 
1.3 Tumor necrosis factor in the CNS 
1.3.1 Characteristics of tumor necrosis factor 
Tumor necrosis factor (TNF) was first used in 1975 by Lloyd Old 
and coworkers. This stemmed from an experiment in which mice or rabbits 
were treated with "Bacille Calmette-Guerin (BCG)" for 10-14 days, followed 
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by an injection of lipopolysaccharide (LPS), and this treatment led to the 
release of TNF into circulation (Old, 1985). It is now known that TNF 
includes two structurally and functionally related proteins, TNF-a and TNF-
6 or lymphotoxin�TNF-(X is produced mainly by monocytes/macrophage 
lineage, whereas TNF-6 is a product of lymphoid cells (Vilcek and Lee, 
1991). 
As the name implies, TNF was originally discovered to have 
antitumor abilities. TNF containing serum can cause a rapid haemorrhagic 
necrosis and regression on transplantable, methylcholanthrene induced 
sarcoma (Fiers, 1991). In addition to causing tumor necrosis, TNF also has 
a wide spectrum of functions. For example, TNF-a can markedly stimulate 
lipolysis and glycogenolysis in adipocytes and skeletal myocytes (Torti et 
al., 1985; Lee et al., 1987). TNF-a, as well as lymphotoxin, can both 
stimulate bone and cartilage resorption (Bertolini et al., 1986). 
Like that of other cytokines, TNF can amplify the immune responses. 
For example, TNF-a enhanced the proliferation of IL-2-dependent T cells, 
and the expression of MHC antigen and high-affinity IL-2 receptors 
(Scheurich, 1987; Ranges et al., 1989). Also, TNF-a can trigger the 
production of a number of other regulatory cytokines, such as IL-1, IL-6, 
IFNs, TGF-a, TGF-6, granulocyte-macrophage colony stimulating factor 
(GM-CSF) and platelet-derived growth factor (PDGF) from lymphocytes 
、 . 
(Fiers, 1991). 
1.3.2 Sources of TNF in the CNS 
In the normal brain, TNF cannot be found in the cerebrospinal fluid, 
but only be found during inflammation, such as demyelinating disease or in 
brain injuries. For example, TNF can be detected in multiple sclerosis (MS), 
a chronic inflammatory and demyelinating disease of the CNS. It has been 
a good model used by many investigators to study the role and the source 
of TNF (Martin and Tracey, 1992; Sharief and Thompson, 1992). It has 
been reported that rapid migration of activated T cells into the CNS was 
observed during an inflammatory response (Hafler and Weiner, 1987). In the 
cerebrospinal fluid of MS patients, the leukocytes consisted of 5% 
macrophage, 94% T cells and 1% B cells (Merrill et al., 1989), which 
provide a rich source of TNF. Most of the TNF may came from infiltrating 
lymphocytes or macrophages. In brain injuries, where there is a breakdown 
of blood-brain barrier (BBB), migration of monocytes or macrophages to the 
CNS occurs, which may result in the stimulation of TNF secretion from 
these cells as well as astrocytes. 
Apart from the immunocompetent cells in the peripheral immune 
system, astrocytes and microglia in the CNS can also secrete TNF-a when 
induced by LPS, IFN-x and IL-1 (Sawada et al., 1989; Chung and 
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Benveniste, 1990). However, since TNF-a secretion from astrocytes and 
microglia is a time-dependent process, it might not be an immediate source 
for TNF but rather a long term source in the brain. 
1.3.3 Functions of TNF in the CNS 
In CNS inflammation, TNF exerts various immune functions in the 
brain. It augments IFN-T induction of MHC class I and class II expression 
on astrocytes and brain endothelial cells (Male and Pryce, 1988; Vidovic et 
al., 1990). In addition, TNF-a can induce the expression of intracellular 
adhesion molecules (ICAM-1) on astrocytes (Frohman et al., 1989a, b) and 
brain endothelial cells (Hughes et al., 1988). Upon the expression of ICAM-
1，the adhesion of lymphocytes to these two cell types were increased, 
implying that TNF-a may trigger the migration of peripheral lymphocytes 
infiltrating into the brain. TNF also stimulate the expression and secretion 
of IL-1 and IL-6 in astrocytes (Frei et al., 1989; Aloisi et al., 1992), 
Although TNF can enhance the immune responses in the CNS, TNF also 
induces certain harmful effects. For example, it is cytotoxic to 
oligodendrocytes and causes demyelination (Robbins et al.，1987; Selmaj 
and Raine, 1988), and such lesion will ultimately lead to neuronal cell death 
and the formation of glial scar. 
Apart from immunological functions, TNF plays a number of 
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neuromodulatory roles. For example, chronic treatment of neonatal rat 
superior cervical ganglia with TNF exhibited an increase in Ca^^ current 
density (Soliven and Julyan, 1992). TNF modulates the inactivation of 
catecholamine secretion in cultured sympathetic neurons (Soliven & Albert, 
1992). In addition, TNF and IL-16 synergistically stimulates nerve growth 
factor (NGF) release from cultured rat astrocytes (Gadient et al., 1990). 
1.3.4 TNF and signal transduction 
Although TNF has pleiotropic effects on different cell types, only two 
TNF receptors are discovered. They are receptors p53 and p75, which are 
coexpressed on the surface of most cells (Brockhaus et al., 1990; Shalaby 
et al., 1990). There are many reports showing that interaction between TNF 
and its receptor stimulates receptor internalization to induce its cytotoxic 
effect on tumor cells, but not receptor recycling except in MCF 7 cells 
(Watanabe et al., 1988; Vuk-Pavlovic and Kovach, 1989). 
The role of TNF in signal transduction remains a matter of 
controversy. Although internalization of ligand-receptor complex may play 
a role in the induction of certain cellular responses, there are other reports 
showing that immediate intracellular TNF effects can be induced under the 
conditions that preclude internalization. These effects includes, for example, 
activation of protein kinases, phosphorylation of a 26-Kd cytosolic protein 
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was also observed (Schutze et al., 1989). Furthermore, direct stimulation of 
GTPase activity from the study of TNF signal transduction in human 
myeloid HL60 cells and that in the murine fibrosarcoma cell line L929 
(Imamura et al., 1988) have been reported. 
In addition, several laboratories have demonstrated that TNF activates 
phospholipase A�（PLA!) in different cell types, such as chondrocytes 
(Suffys et al., 1988), rat renal mesangial cells (Pfeilschifter et al., 1989), 
bovine endothelial cell line (Clark et al., 1988)，human FS-4 fibroblasts 
(Hori et al., 1989) and BALB/3T3 fibroblasts (Palombella et al., 1989). 
Upon activation, PLA� cleaves arachidonic acid from phospholipids and 
increases eicosanoid synthesis. In BALB/3T3 fibroblasts, PLA� activation 
can be associated with both growth-stimulatory and growth-inhibitory 
activities of TNF (Palombella et al., 1989). 
Moreover, TNF was shown to activate phosphatidylcholine (PC)-
specific phospholipase, thus producing diacylglycerol (DAG) from 
phosphatidylcholine (Schutze et al., 1991)，and they proposed that PC rather 
than PIP2 serves as a source for TNF-induced DAG production. 
In the human fibroblast cell line FS-4, and in rat mesangial cells, 
TNF was reported to enhance cAMP production rapidly, potentially resulting 
in the activation of protein kinase A (PKA) (Zhang et al., 1988; Baud et al., 
1988). The involvement of protein kinase C (PKC) in TNF signalling 
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pathways was shown in lymphocytic (Jurkat), monocytic (U937) and 
erythroid (K562) cell lineage (Schiitze et al., 1990). 
Apart from its actions on various second messenger systems, TNF 
can also induce third messengers signalling pathways, for example, the 
induction of TNF-sensitive nuclear transcription factors, like that of steroid 
hormones. It was reported that TNF can induce a well-known transcription 
factor, nuclear factor (NF)4B (Duh et al., 1989; Lowenthal et al., 1989; 
Osbom et al., 1989). (NF)-lfB is present in theV-immunoglobulin light chain 
gene and it is a pleiotropic transcription factor that controls the expression 
of a variety of cellular genes, so called TNF-responsive genes. 
At present, little is known about TNF and cGMP interaction, as well 
as the effects of TNF on protein phosphorylation in astrocytes. It will 
therefore of interest to examine the effects of TNF on these two aspects. 
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1.4 cGMP second messenger system in astrocytes 
1.4.1 cGMP as second messenger in astrocytes 
Cyclic guanosine monophosphate (cGMP) was discovered in 1963 
(reviewed by Lincoln and Comwell, 1993). Studies from photoreceptor cells 
of the retina showed that it is an intracellular signal in the CNS (Miller, 
1983). Evidence of cGMP as second messenger in astrocytes came mainly 
、 . 
f 
from the study of different natriuretic peptides. For example, atrial 
natriuretic peptide has been identified in the CNS and its binding sites are 
predominantly located on astrocytes (De Vente et al., 1989; Simonnet et al., 
1989). Brain natriuretic peptide, a 26-amino acids peptide, and C-type 
natriuretic peptide (CNP) were also found to have binding sites on astrocytes 
(Yeung et al., 1991，1992a, b). Irrespective of which types of natriuretic 
peptide bounds to astrocytes, they both result in cGMP production. 
Therefore, cGMP may be an alternative second messenger system in 
astrocytes other than the well-known cAMP and protein kinase C. 
1.4.2 Post cGMP cascade effects 
There are three major classes of cGMP receptor proteins for cGMP 
in eukaryotic cells: cGMP kinases, cGMP-regulated ion channels, and 
cGMP-binding cyclic nucleotide phosphodiesterases (PDEs) (Lincoln and 
Comwell, 1993). cGMP can either stimulate or inhibit protein 
phosphorylation, depending on the cell types used. cGMP was shown to 
regulate channel conductance in photoreceptor cells of retina. However, 
there has been no report suggesting which types of cGMP receptor protein 
is present in astrocytes. 
1.5 The aims of this project 
、 . 
Astrocytic swelling is a common early phenomena in brain injuries, 
ischemia, hypoglycermia and encephalomyelitis (Kimelberg and Ransom, 
1986). After cellular swelling, cell volume will again be restored to the 
normal size, a process termed RVD. In the process of cell swelling and 
RVD in astrocytes, the cellular content of osmolytes would change. One of 
the most important organic osmolytes is taurine, which is an essential 
component for volume or osmolarity regulation. 
In addition to the osmotic changes observed after the brain injuries, 
the break down of blood-brain-barrier (BBB) is often a response also 
observed. The breakdown of the BBB would induce the entry of 
lymphocytes or macrophage into the brain and thus the exertion of their 
immunological effects. One of these immune responses in the brain is the 
secretion of certain cytokines, such as TNF for the intercellular 
communication and further amplification of the responses. The action of 
TNF on astrocytes would again lead to the secretion of more TNF and other 
cytokines. However, apart from the well-known immunological functions of 
TNF, especially in the peripheral system, little is yet known about other 
neuromodulatory functions in the brain. In this project, one aspect of its 
neuromodulatory role in the CNS will be explored, particularly its effect on 
taurine transport in astrocytes. It is because taurine is an osmoregulator in 




Firstly, the effects of TNF on taurine uptake and release were 
examined. Astrocytes from different sources, such as mouse primary 
astrocytes and rat glioma cell line were used to test the species specificity 
of the effects of TNF on taurine uptake. Also, throughout this project, 
taurine transport in astrocytes cultured in three treatment media: serum-free, 
serum-containing and serum plus dbcAMP, representing three differentiation 
states of astrocytes (Fischer et al., 1982; Weibel et al., 1984; Ransom, 
1991)，was also examined in order to find out whether astrocytes in different 
differential states vary in their taurine uptake capability. 
Since the interaction of TNF and astrocytes would induce many 
cellular responses, the effects of TNF on other transport systems were also 
examined in order to identify the specificity of the effects of TNF on taurine 
transport. In this context, the transport of amino acids，such as tyrosine, 
glutamate and leucine; neurotransmitters, such as norepinephrine (NE), 
dopamine (DA) and 4-aminobutyiic acid (GABA); and also that of glucose 
were examined. 
Lipopolysaccharide (LPS), an inflammatory signal which can induce 
TNF secretion in astrocytes (Chung and Benveniste, 1990) was also used in 
order to further verify that the increased taurine uptake was stimulated by 
TNF and the source of TNF was from astrocytes. The results of this will be 
compared to that of direct TNF exposure. 
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In order to further test the specificity of the effects of TNF, other 
cytokines, such as x-interferon (IFN-t) was employed to test its effects on 
taurine uptake. Since TNF and IFN-t have synergistic effects on MHC class 
II expression in cultured astrocytes (Benveniste et al., 1989)，this study will 
establish whether IFN-x had similar taurine uptake patterns to that of TNF. 
Since there are some reports showing that TNF can induce PKC in 
other cell types (Schiitze et al., 1990), and PKC second messenger system 
was shown to increase taurine release (Lee et al., 1992), phorbol 12-
myristate 13-acetate (PMA), a protein kinase C activator, was employed to 
test if PKC can affect taurine uptake as well. 
Secondly, to test the effects of TNF on metabolic changes in 
astrocytes cGMP level, protein phosphorylation and Ca^ ^ uptake were 
examined. Results from these may suggest the mechanisms whereby TNF 
exerts its effects on astrocytes. To further test the intracellular changes in 
TNF on astrocytes, cell proliferation, RNA synthesis and protein synthesis 
were examined using [^H]-thymidine, [^H]-uridine and [^H]-leucine, 
respectively. 
、 . 





CHAPTER II METHODS 
V 
2.1 Primary astrocytes culture 
2.1.1 Primary rat astrocytes culture 
New bom Sprague-Dawley rats cultured in the Chinese University 
animal house were used in this project. All procedures were carried out 
under strict sterile condition. Animal were killed by decapitation and the 
heads were rinsed with 70% alcohol. The brains were removed and the 
cerebral cortices were isolated. The meninges were removed under a 
dissecting microscopy and the cerebral cortices were minced in cold sterile 
Ca2+- and Mg^^-free Hank's balanced salt buffer (HBSS, supplemented with 
15mM HEPES and 0.35g sodium bicarbonate in IL, pH7.4, Sigma). The 
brain tissues were trypsinized in 0.125% trypsin solution (1:1 vol/vol of 
0.25% trypsin solution : HBSS) for 12 minutes at 3 7 � C The enzyme 
reaction of trypsin was stopped by the addition of one fold serum-containing 
medium. The suspension was centrifuged at 2200 rpm for 5 minutes 
(Centaur 2，MSE). The pellet was resuspended and dissociated with I8V2 
gauge needle and syringe. The cells were further dissociated with a 70pm 
pore size sterile nylon Nitex sieves (146490，Spectrum & Spectra/Mesh, 
Spectrum Medical Industries Inc.) 
Cell viability was monitored using trypan blue (Sigma) (Philip, 1973) 
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and the total number of cells were counted on a haemocytometer and the 
mixture was diluted to a plating density of 2 x 10^  cells/75 cm^ culture flask 
(Falcon, Becton Dickinson & Company). The cell were incubated in a 
humidified incubator under 5% COJ 95% air at 37°C. The culture medium 
was changed after three days of seeding and subsequently twice weekly. The 
culture medium is composed of Dulbecco's modified Eagle's medium 
containing Ham's nutrient mixture F-12 supplemented with 10% heat 
inactivated fetal bovine serum, 1% penicillin (1,000 unit/ml) and 1% 
streptomycin (1,000 pg/ml). 
After 10 to 14 days of incubation, when the cells reached a 90% 
confluency, microglia, oligodendrocytes and other contaminating cells were 
removed by shaking at 280rpm for 18-20 hours in 37�C (Lab-Line Orbit 
Environ-shaker). After shaking, the non-adherent cells were removed and the 
attached cells, which consisted of mainly astrocytes, were washed twice with 
BBSS. The cells were then cultured in complete Waymouth medium MB 
752/1 (serum-free medium without HEPES, pH7.2, Sigma). The serum-free 
(SF) medium was changed twice a week to further decrease the survival of 
remaining microglia, oligodendrocytes and type-2 astrocytes progenitor cells 
and fibroblasts. Astrocytes cultured in serum-free medium will not further 
differentiate and could be maintained for a period of up to one month. 
Astrocytes used for this study were conditioned in serum-free medium at a 
purity level of 85-95%. 
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Prior to the biochemical assays, the astrocytes were subcultured onto 
24-well culture plates (Nunc, Nunclon Delta, Denmark) for seven days in 
serum-free medium at a plating density of 1 x 10^  cells/well. Astrocytes 
used for protein phosphorylation or cGMP assay were plated onto 6-well 
plates (Coming Glass Work, N.Y.) at a plating density of 1 x 10^  cells/well. 
2.1.2 Primary mouse astrocytes culture 
The method of primary culture for mouse (ICR) astrocytes was the 
same as that for rat astrocytes. However, the mouse astrocytes took 15-18 
days to reach confluence, which was slightly longer than that for rat 
astrocytes. ICR mice were obtained from the Chinese University Animal 
House. 
2.1.3 Culture of rat C6 glioma cell line 
C6 glioma cells were obtained from American Tissue Culture 
Association (Rockville, MD, U.S.A.). It is an adherent cell line and grows 
in a monolayer. C6 glioma cells were cultured in T-25 tissue culture flask 
(Corning Glass Work, N.Y.) in serum-containing medium and incubated at 
37°C in 5% COj / 95% air humidified incubator. Cells were subcultured 
every four days. 
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2.1.4 Subculture of astrocytes in different media 
24 hours after subculture of astrocytes onto culture wells, the serum-
containing medium was changed to three different culture media: serum-free 
chemically defined medium (SF), 100ml serum-free medium consisting of 
Waymouth medium MB 752/1 with the addition of 5pg/ml sterile insulin 
(Sigma), 0.5mg/ml sterile BSA (fatty acid free, fraction V) (Sigma), 1,000 
unit/ml penicillin and 1,000 pg/ml streptomycin, GIBCO, Grand Island, N. 
Y. USA); serum-containing medium (S)，10% heat-inactivated fetal bovine 
serum (HIFBS) (Fetal bovine serum in 56�C for 40 minutes, GIBCO), with 
1% penicillin (1,000 unit/ml) and 1% streptomycin (1,000 pg/ml) (GIBCO) 
added to 100ml DF medium; and serum plus dibutyryl cyclic AMP 
(dbcAMP) medium (SC), DF serum-containing medium with the addition 
of 0.25mM of dbcAMP. The culture medium was changed twice a week� 
Astrocytes were cultured in these three different media for six days prior to 
all experimentation. However, C6 glioma cells were cultured for four days 
instead of six days in the three treatments. 
Cells cultured in serum-free medium (SF), represent a relatively 
undifferentiation state. The cells were protoplasmic in shape with little 
y branching process (Fig, 2.1a). Cells grown in serum-containing medium (S) 
differentiate and proliferate continuously, so some branching processes could 
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Fig. 2.1: Phase contrast micrographs of primary rat astrocytes 
cultured in (a) serum-free chemically defined medium, (b) serum-








be observed (Fig. 2.1b). As for the cells cultured in serum plus dbcAMP 
medium (SC), astrocytes were promoted to differentiate and proliferate into 
a more mature state than its SF counterpart. Numerous branching processes 
could be observed (Fig. 2.1c). 
2.2 Taurine uptake and release assay 
2.2.1 Taurine uptake assay 
Astrocytes were cultured in 24-well plates in serum-free, serum-
containing and serum plus dbcAMP media for six days before taurine uptake 
assays. Prior to the uptake assay, astrocytes were washed twice with 
physiological buffer (3mM KCl, 122mM NaCl, lOmM glucose, 12mM 
KH2PO4, 1.2mM MgS04-7H20, 1.3mM CaCVSHaO，20mM HEPES and 
5mM NaHC03, pH 7.4). Then, 0.25ml of physiological buffer containing 
0.2pCi/well [^H]-taurine (28Ci/mmole, Amersham, England) at a final 
concentration of 0.3mM was added to each well. Astrocytes were incubated 
with [^H]-taurine for 40 minutes in 5% CO! / 95% air at 37°C. [^H]-taurine 
containing buffer was subsequently removed and the cells were washed 
twice with ice-cold physiological buffer. Cellular protein was solubilized by 
0.2ml IM NaOH. 1ml scintillant (0.4g POPOP, 4g PPO dissolved in one 
litre mixture of 666ml toluene and 333ml triton-XlOO) was added to lOOpl 
aliquot of solubilized solution and the radioactivity of [^H]-taurine was 
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quantitated by liquid scintillation spectrometry (Beckman LS 1801 liquid 
scintillation counter). 80pl aliquot of solubilized solution diluted to 0.4ml 
was used for protein determination using the Folin method (Lowry et al” 
1951) and bovine serum albumin (BSA, Sigma) was used as standard. 
Protein concentration was determined by reading the absorbance at 750nm 
using a Shimadzu UV-1201 spectrophotometer. 
To study the kinetic of taurine uptake, astrocytes were incubated with 
different concentrations of taurine (O.OlmM, O.lmM, 0.8mM and lOmM) for 
40 minutes and all the procedures were the same as above. To study the 
time course of taurine uptake, astrocytes were incubated with physiological 
buffer containing ImM taurine for different periods of incubation time (5, 
10，30, 60，90, 120 minutes), and the rest of experimental procedures were 
the same as above. 
Taurine uptake was expressed as nmole of taurine taken up per mg 
of cellular protein in each culture well (nmole/mg of protein). The equations 
of the calculation were as follows: 
Fraction of taurine uptake = 
Radioactivity of lOOpl solubilized solution (cpm) 
Radioactivity of [^H]-taurine in the incubation medium (cpm) 
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Degree of taurine uptake = 
Fraction of taurine uptake x amount of taurine in the incubation medium (nmole) 
mg of protein in each well 
Taurine uptake between the different groups were compared using a 
Student Mest, significance is p < 0.05 and each experiment was repeated 
three times. 
2.2.2 Taurine release assay 
Astrocytes were cultured in a 4-well plate (Nunc, Nunclon Delta, 
Denmark) with a seeding density of 1 x 10^  cells/well and were first washed 
twice with physiological buffer at 37°C. The cells were pre-incubated for 40 
minutes with 0.25ml physiological buffer containing [^H]-taurine 
(1.182pCi/well) at a final concentration of 0.3mM. Prior to release assays, 
the buffer was removed and the cells were washed twice with 0.25ml 
physiological buffer (37°C). Then, 0.25ml of fresh physiological buffer at 
37°C was added to each well. At the indicated periods of time (1，5, 10，15, 
20 minutes), the buffer was removed and the [^H]-taurine released was 
determined. 
The results of taurine release were expressed as fractional release 
(%). Fractional release (%) was calculated with the following equation: 
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Fractional release (%)= 
Fractional release of pH]-taurine at each time point (cpm) 
[Accumulated fractional release of [^H]-taurine for all time point (cpm) 
+ pH]-taurine remained in the cells (cpm)] 
The significance between different groups were examined using the 
Student Mest, significance is p < 0.05 and each experiment was repeated 
three times. 
2.3 The effects of TNF on taurine transport 
In order to study the effects of TNF on taurine transport, astrocytes 
were primed with TNF (human recombinant TNF, lOpg/ml, Boehringer 
Mannheim Biochemica, Germany). TNF was aliquoted and stored at -20°C 
without dilution. 
48 hours prior to the taurine uptake or release assay, astrocytes were 
preincubated with 20ng/ml TNF containing culture medium. In order to 
study the effects of TNF exposure time on taurine uptake, astrocytes were 
incubated with 20ng/ml TNF for 4，12, 24, 48 and 72 hours before the 
uptake assay. In order to study the TNF dose-dependent experiment, the 
cells were incubated with TNF in different concentrations, such as 5，10，20, 
50 and lOOng/ml for 48 hours. 
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2.4 The effects of TNF on cell volume in astrocytes 
3-0-methyl-[^H]-glucose (30MG, Amersham, U. K.)，a non-
metabolized glucose analog, was used to study the effects of TNF on cell 
volume changes. 30MG has been employed as an index of cell volume 
because it is taken up into the cells with water until equilibrium (Kimelberg 
and Frangakis, 1985). Astrocytes were cultured in SF, S and SC media with 
or without 20ng/ml TNF for 48 hours prior to the experiment. The cells 
were subsequently washed twice with physiological buffer without glucose 
(37°C) and then incubated with 30MG (0.435mCi/well, specific activity: 
5Ci/mmole) in 0.25ml of buffer at 37°C for 10 minutes. Astrocytes were 
then washed twice with ice-cold glucose containing physiological buffer. 
Radioactivity and the amount of protein were determined in the same 
manner as that for taurine uptake. The results were expressed as pi of 
water/mg of protein. This experiment was repeated three times. 
2.5 The effects of TNF on amino acids, glucose and 
neurotransmitters uptake 
2.5.1 The effects of TNF on amino acids uptake 
In order to study the specific effects of TNF on taurine transport, the 
effects of TNF on different transport systems, namely tyrosine, glutamate 
and leucine were chosen for this study. Astrocytes were incubated with 阳：-
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tyrosine (specific activity: 45Ci/mmole), [^H]-glutamate (specific activity: 
22Ci/mmole) or [^H]-leucine (specific activity: ImCi/mmole) (All from 
Amersham International pic., U.K.) at a final concentration of 0.3mM in 
0.25ml physiological buffer at 37°C. Other procedures were the same as 
those for taurine uptake measurements (Section 2.2). 
The uptake procedures were identical to that of taurine uptake 
(Section 2.2). Upon completion of the 40 minutes incubation, 0.2ml 7.5% 
ice-cold TCA was added to the cells and the culture plates were kept at 4°C 
overnight to precipitate cellular protein. 1ml scintillant was added to lOOpl 
TCA soluble fraction and the radioactivity of this fraction was counted. 
While the TCA-insoluble fraction was solubilized by 0.2ml IM NaOH 
overnight, any labelled amino acids incorporated into cellular proteins would 
also be solubilized. lOOpl of the solubilized solution was removed from this 
NaOH solubilized fraction and the radioactivity was measured in order to 
assess the amount of labelled amino acids that were incorporated into the 
protein. Another 80pl of the solubilized solution was removed for protein 
determination. This procedure enables the distinction of labelled amino acids 
incorporated into cellular proteins from those that were taken up 
intracellularly. The results were expressed as nmole/mg of protein and the 
experiment was repeated three times. 
2.5.2 The effects of TNF on glucose uptake 
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3-0-methyl-[^H]-glucose (Amersham, U.K.), a non-metabolized 
glucose analog, was used to determine the effects of TNF on glucose uptake. 
Astrocytes were washed twice with physiological buffer without glucose at 
37°C prior to glucose uptake assay. The cells were incubated with 3-0-
methyl-[^H]-glucose (Specific activity: 5Ci/mmole) at a final concentration 
of 0.3mM in 0.25ml physiological buffer at 37�C for 40 minutes. The cells 
were subsequently washed twice with ice-cold glucose- containing 
physiological buffer. The radioactivity and the amount of protein were 
determined in the same manner as that for taurine uptake. The results were 
expressed as nmole/mg of protein. The experiment was repeated three times. 
2.5.3 The effects of TNF on neurotransmitters uptake 
[^H]-Norepinephrine (specific activity: 37Ci/mmole),阳]-dopamine 
(specific activity: 12.5Ci/mmole) and [^H]-GABA (specific 92.5Ci/mole) 
(Amersham, U.K.) were used to determine the effects of TNF on 
neurotransmitter uptake. Since these neurotransmitters would be easily 
degraded in the cell, an inhibitor, such as ImM pargyline (Sigma, U.S.A.) 
was included in norepinephrine and dopamine experiments, and 0.03M 
(aminooxy) acetic acid (AOAA, Sigma, U.S.A.) in GABA experiment. All 
solutions of unlabelled neurotransmitters were freshly prepared. 
The procedures for neurotransmitter uptake were the same as 
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described by Iversen (1973), similar to those of taurine uptake. Briefly, the 
cells were first washed twice with physiological buffer at 37°C and were 
incubated with labelled neurotransmitters at the final concentration of 
0.3mM in 0.25ml of physiological buffer at 37�C for 20 minutes. The cells 
were then washed with ice-cold physiological buffer and the amount of 
radioactivity measured similarly as in taurine uptake experiment. The results 
were expressed as nmole/mg of protein and the experiment was repeated 
three times. 
2.6 The effects of LPS on taurine uptake in astrocytes 
Lipopolysaccharide (from E. Coli. 026:B6, Sigma) dissolved in HBSS 
was added to the culture medium in the concentration of 1，10 and 
lOOng/ml. Astrocytes were incubated with or without LPS-containing 
medium for 48 hours before the taurine uptake experiment. Subsequent 
procedures were the same as TNF studies (Section 2.3). The experiment was 
repeated twice. 
2.7 The effect of IFN-T on taurine uptake in astrocytes 
In order to study the effect of IFN-T on taurine uptake, astrocytes 
cultured in SF , S and SC media were incubated with IFN-T (mouse 
recombinant IFN-T , 100,000 U/ml, Boehringer Mannheim Biochemica, 
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Germany) for 48 hours prior to the uptake experiment. The procedures of 
taurine uptake assay were the same to those described in Section 2.2.1. This 
experiment was repeated twice. 
2.8 The effects of PMA on taurine uptake in astrocytes 
Phorbol 12-myristate 13-acetate (PMA, Sigma) was dissolved in 
dimethylsulfoxide (DMSO, Sigma) to give a concentration of lOmM. 
Astrocytes were incubated with 5 and lOpM of PMA in the dark for 48 
hours prior to taurine uptake assay. The cells were washed twice with 
physiological buffer at 37°C and the subsequent procedures for taurine 
uptake was similar to that described in 2.1.1. The results were expressed as 
nmole/mg of protein and the experiment was repeated twice. 
2.9 The effects of TNF on thymidine, uridine and leucine 
incorporation in astrocytes 
[^H]-thymidine, [^H]-uridine and [^H]-leucine (ImCi/ml, Amersham 
International pic., U.K.) were used to measure thymidine, uridine and 
leucine incorporation respectively. Astrocytes cultured in 96-well plates 
(Nunc, Nunclon Delta, Denmark) with the seeding density of 1 x 
cells/well were primed with 20ng/ml TNF for 48 hours prior to 
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incorporation studies. 2pl of one labelled substrate was added directly to the 
cells and further incubated for 20 hours. At the time of cell harvesting, the 
medium was removed and the cells were washed twice with ice-cold 
physiological buffer. 0.2ml 7.5% ice-cold TCA was then added to the wells 
and were kept at 4°C for 30 minutes. TCA was subsequently discarded and 
the cells were solubilized in IM NaOH overnight. Radioactivity was 
measured in a liquid scintillation counter (Beckman LS 1801，U.S.A.). 
Results are expressed as count per minutes (cpm) and the experiment was 
repeated twice. 
2.10 The effects of TNF on basal level of cGMP in astrocytes 
In order to study the effect of TNF on the basal level of cGMP, 
astrocytes cultured in 6-well plates (Corning Glass Work, N.Y.) with the 
density of 1 x 10^  cells/well were used. The cells were cultured in SF, S and 
SC media for six days and were primed with 20ng/ml TNF for 48 hours. 
Prior to cGMP measurements, the cells were washed twice with 
physiological buffer at 37°C. This, 0.7ml of 7.5% ice-cold TCA was added 
to each well to stop the reaction. The cells were then scratched off and 
transferred to eppendorf tubes. The suspension was centrifuged and the 
pellet was removed. The supernatant, containing all soluble cellular content 
including cGMP, was washed 4 times with 4 volumes of water-saturated 
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ether to remove residual TCA. The residual trace of ether was aspirated off 
by suction. The level of cGMP in the aqueous phase was determined using 
a cGMP assay kit (Amersham, U.K.). The results were expressed as 
pmole/mg of protein and the experiment was repeated twice. 
2.11 The effects of TNF on protein phosphorylation in astrocytes 
Astrocytes cultured in 6-well plates with the density of 1 x 10^  
cells/well were used for the protein phosphorylation assay. The cells were 
cultured in SF, S and SC media with or without 20ng/ml TNF for 48 hours 
prior to the experiment. Two ml of ice-cold lOmM Tris buffer (pH 7.4) was 
added to each well and the cells were scratched off. The cells were further 
disrupted with 4X 10 seconds high power sonication. Protein contents in 
each sample were normalized by dilution, preincubated at 37°C for 20 
minutes and incubated further with or without 20ng/ml TNF for 10 minutes. 
The samples were then incubated with [^^P]-ATP (IpCi/tube, 
0.33pmole/tube) in a volume of 15pl for 5 minutes. The reaction was 
stopped by the addition of bromophenol blue containing sample dilution 
buffer (2% 2-mercaptoethanol, 20% glycerol, 25% 0.5M Tris, 2% SDS and 
4x10^% bromophenol blue). The samples were then applied onto SDS-PAGE 
(12.5%) minigel system (Biorad). The sample were run at constant current 
of 40mA and at a voltage of 150V for one and a half hour. The gel was 
then covered with a X-ray film (X-OMAP AR film, Kodak), exposed for 10 
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hours and the film was developed. The bands shown in the X-ray film were 
scanned by a scanner and reproduced. 
2.12 The effects of TNF on calcium uptake in astrocytes 
Astrocytes used for calcium uptake were cultured as described in 
Section 2.1.1. Prior to the uptake studies, astrocytes were washed twice 
with low calcium (0.03mM Ca2+) MCDB 151 medium (Sigma, U.S.A.) at 
37°C. The cells were then incubated with lOpCi/ml of (specific 
activity: lOmCi/ml, NEN, U.S.A.) in MCDB 151 medium for 5 minutes at 
37°C. The cells were then rapidly washed twice with ice-cold physiological 
buffer and subsequently solubilized with IM NaOH. The results were 





CHAPTER III RESULTS 
3.1 The effects of TNF on taurine transport in cultured rat astrocytes 
Since taurine is one of the most important osmoregulators and TNF can 
be secreted by astrocytes themselves, the effects of TNF on taurine transport 
was examined. In order to study the effects of TNF on taurine transport in 
cultured astrocytes, firstly, the effects of TNF on the time course of [^H]-
taurine uptake in astrocytes cultured in SF, S and SC media were studied to 
obtain the optimal incubation time for [^H]-taurine, which will then be used 
for subsequent experiments. Secondly, the effects of TNF on taurine uptake 
in astrocytes incubated with different concentrations of taurine (shown in 
Section 3.2) were examined. Kinetic parameters, such as and V讓，of 
taurine uptake in the presence or absence of TNF were studied. In addition, 
the optimal concentration of taurine for the subsequent experiments could be 
selected from these results. Thirdly, taurine uptake in astrocytes primed with 
various concentrations of TNF and for various periods of time (shown in 
Section 3.3 and 3.4) were studied. These results can indicate the time required 
to observe the optimal effect of TNF and whether the effect of TNF was 
dose-dependent. 
The effects of TNF on taurine efflux was also examined in order to 
have a more definite picture on its effect on the taurine transport system. In 
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addition, the effects of TNF on cell volume change was studied in order to 
investigate if the effect of TNF on taurine transport was not due to its effects 
on cell volume. 
The effects of TNF on taurine uptake were compared amongst in 
cultured astrocytes from rat, mouse and C6 glioma in order to test the species 
specificity of its effect. 
Since other inflammatory signal, such as lipopolysaccharides (LPS) 
have been shown to induce TNF secretion in astrocytes (Chung and 
Benveniste, 1990)，the effects of LPS on taurine uptake was examined in 
order to known if the interaction of LPS and astrocytes can affect taurine 
uptake. 
In all these experiments, taurine transport in astrocytes cultured in 
serum-free (SF), serum-containing (S) and serum plus dbcAMP (SC) media 
representing different maturation states of astrocytes, were also compared. 
3.1.1 The effects of TNF on [^H]-taurine uptake - time course 
study 
Preliminary studies showed that TNF in 20ng/ml can stimulate taurine 
uptake in cultured astrocytes. 48 hours incubation, with 20ng/ml TNF and 
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ImM taurine was used initially to test the timing of [^H]-taurine uptake, 
although the optimal concentration of taurine, the incubation timing of TNF 
and the concentration of TNF were examined in the subsequent experiment. 
Fig. 3.1 showed the results of [^H]-taurine (0.44pCi/well, at a final 
concentration of ImM) uptake in astrocytes cultured in SF, S and SC media 
without being primed with TNF. Time-dependent increase in [^H]-taurine 
uptake was observed from 5 minutes to 120 minutes. Maximal [^H]-taurine 
uptake was reached at 90 minutes and after this time a slight decrease was 
observed. At 90 minutes, pH]-taurine uptake in astrocytes cultured in S (38.9 
土 0.3 nmole/mg of protein) and SC (21.3 土 0.2 nmole/mg of protein) media 
was about 28% and 15.4% that of in SF medium (138.0 土 10.3 nmole/mg of 
protein) respectively. These findings showed that taurine uptake activity in 
astrocytes was time-dependent and its uptake on astrocytes cultured in the 
three media were different. 
Fig. 3.2a, b and c showed [知-taurine uptake from 5-120 minutes in 
astrocytes primed with 20ng/ml TNF for 48 hours. With the increasing time 
of [^H]-taurine incubation, i.e. from 30，60’ 90 to 120 minutes, the percentage 
increase in [^H]-taurine uptake in the cells primed with TNF became larger, 
as compared to the uptake at the corresponding time. Fig. 3.2a showed taurine 
uptake in the TNF-primed astrocytes cultured in SF medium. [^H]-taurine 
uptake at 90 minutes was increased by 19% (p<0.05) from 138 土 1 nmole/mg 
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of protein to 164 土 1 nmole/mg of protein. In TNF-primed astrocytes grown 
in S medium (Fig. 3.2b), [^H]-taurine uptake was increased by 56% (p<0.05) 
from 38.9 土 0.3 nmole/mg of protein to 60.8 土 0.2 nmole/mg of protein. On 
the other hand, [^H]-taurine uptake was increased by 91% (p<0.05) from 21.3 
土 0.1 nmole/mg of protein to 40.7 土 0.2 nmole/mg of protein in TNF-primed 
astrocytes cultured in SC medium (Fig. 3.2c). Therefore, the stimulation was 
most obvious in astrocytes cultured in serum-containing and serum plus 
dbcAMP media and the effect of TNF can be observed starting from 30 
minutes of incubation (Fig. 3.2b, c). However, for the cells cultured in SF 
medium, the increase of [^H]-taurine uptake was much smaller. 
3.1.2 The effects of TNF on the kinetic parameters of the taurine 
uptake system 
In order to understand how TNF affects taurine uptake and why 
astrocytes cultured in different media differ in their taurine uptake activity 
(Fig. 3.2a, b, c), the K^ and V咖又 values of taurine uptake in astrocytes 
cultured in the three different media with and without the priming of TNF 
(20ng/ml) were examined. 
Astrocytes were incubated with taurine in the concentration of O.OlmM, 
O.lmM, 0.8mM and lOmM for 40 minutes. The rate of taurine uptake was 
then determined, and the Hanes plot was employed to determined the K^ and 
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Fig. 3.1: Time course of pH]-taurine uptake in astrocytes cultured in 
serum-free, serum (10%) and serum (10%) plus dbcAMP (0.25mM) media. 
Rat cortical astrocytes were cultured in the indicated media for six days. The 
cells were then incubated with [^H]-taurine (0.44pCi/well, ImM) in 0.25ml of 
physiological buffer for different durations as shown in the figure at 37°C. 
Values are shown as means 土 SD and each value was measured in triplicate. 
* p<0.05, significant difference from the corresponding control by using 
Student' r-test. 
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Fig. 3.2a: Time course of pH]-taurine uptakes of astrocytes cultured in 
serum-free medium with or without 20ng/ml TNF. Experimental conditions 
were similar to those described in Fig. 3.1. Cells were incubated with or 
without 20ng/ml TNF for 48 hours prior to the taurine uptake experiment. 
Values are shown as means 土 SD and each value was measured in triplicate. 
* p<0.05, significant difference from the corresponding control by using 
Student's 卜test. 
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Fig. 3.2b: Time course of [^H]-taurine uptake of astrocytes cultured in 
serum-containing (10%) medium with or without 20ng/ml TNF. 
Experimental conditions were similar to those described in Fig. 3.1. Values 
are shown as means 土 SD and each value was measured in triplicate. * 
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Fig. 3.2c: Time course of [^H]-taurine uptake of astrocytes cultured in 
serum (10%) plus dbcAMP (0.25mM) medium with or without 20ng/ml 
TNF. Experimental conditions were similar to those in Fig. 3.1. Values are 
shown as means 土 SD and each value was measured in triplicate. * p<0.05, 
significant difference from the corresponding control by using Student's f-test. 
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Vmax (Wilson & Goulding, 1987) of the taurine transport system and the 
results are shown in Fig. 3.3 and 3.4. 
Fig. 3.3 showed the K^ values of taurine transport in astrocytes 
cultured in SF, S and SC media. Astrocytes cultured in SC medium without 
TNF have the highest K^ value (0.14mM), which was about 4.7 and 1.75 fold 
that for cells grown in S (0.03mM) and SF (O.OSmM) media, respectively. On 
the other hand, the V碰 value for astrocytes cultured in SF medium was the 
highest (0.90 nmole/min/mg of protein), which was about 2.9 and 3.3 fold that 
of cells cultured in S (0.31 nmole/min/mg of protein) and SC (0.27 
nmole/min/mg of protein) media, respectively (Fig. 3.4). Since the V^^x 
indicates the number of taurine transporter, the result of V腿 can partly 
explain why astrocytes cultured in serum-free medium has particularly high 
levels of taurine uptake activity (Fig. 3.1). 
In astrocytes incubated with TNF, cell grown in SC medium also 
showed the highest K^ value (4.48 x IQ-^mM), which is 2.8 and 1.8 fold that 
of cell grown in S (1.58 x lO-^mM) and in SF (2.51 x lO'^mM) media, 
respectively (Fig. 3.3). TNF decreased the K^ values by 70%, 14% and 68% 
in the cells cultured in SF, S and SC media, respectively. As the decrease in 
K^ values implies an increase in the affinity of taurine transporter for taurine, 
suggesting that TNF increases the affinity of taurine for the taurine 
transporters. This may also partly explain why astrocytes grown in TNF have 
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higher activity of taurine uptake irrespective of culture media (Fig. 3.2a,b,c). 
In astrocytes incubated with TNF, cells grown in SF medium also showed the 
highest V咖X (0.90 nmole/min/mg of protein) (Fig. 3.4), which is 2.4 and 2.5 
fold that of those grown in SC (0.37 nmole/min/mg of protein) and S (0.36 
nmole/min/mg of protein) media respectively. These Vmax values, however, are 
increased by 16% and 36.5% in TNF-primed astrocytes cultured in S and SC 
media, with no changes observed in the cells cultured in SF medium. These 
results implied that the priming effect of TNF on taurine uptake may not be 
significantly related to the change in the number of taurine transporters, but 
instead, was related to the increased in the affinity of taurine transporter for 
taurine. 
The highest K^ value obtained for taurine uptake was 0.14mM in 
astrocytes cultured with SC medium (Fig. 3.3). As a result, 0.3mM taurine 
concentration was selected for subsequent experiments, as this concentration, 
which is two to three times the highest K^ value, wi l l be sufficient to saturate 
the taurine transporters. 
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Fig. 3.3: Comparison of the K^ values of astrocytes cultured in three 
treatment media with or without the addition of TNF. Astrocytes were 
incubated with ['H]-taurine at a final concentration of O.OlmM, O.lmM 
0.8mM and lOmM in 0.25ml/well physiological buffer for 40 minutes at 
370c. Cells for TNF treatment were primed with 20ng/ml TNF for 48 hours 
prior to the experiment. Triplicate determinations were performed for each 
concentration and the K^ values for each experiment were obtained from the 
y-intercept of the Hanes plot. 
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Fig. 3.4： Comparison of the V^x values of astrocytes cultured in three 
treatment media with or without the addition of TNF. Exper imenta l 
conditions were the same as those described in Fig. 3.3. V^^^ values for each 
experiment were obtained from the slope of the Hanes plot. 
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3.1.3 The effects of TNF concentration on taurine uptake 
As described previously in Section 3.1, 20ng/ml of TNF was found to 
have stimulatory effects on [^H]-taurine uptake. In this study, 5ng/ml, 
lOng/ml, 20ng/ml, 50ng/ml and lOOng/ml of TNF were used to test whether 
its effect was a dose-dependent one. The optimal concentration in which TNF 
can stimulate taurine uptake was also established. 
Astrocytes were cultured with TNF at the above mentioned 
concentrations for 48 hours prior to the uptake assay. They were then 
incubated with [^H]-taurine (0.2pCi/well) at a final concentration of 0.3mM 
for 40 minutes. 
Fig. 3.5 showed the [^H]-taurine uptake in astrocytes cultured in SF, 
S and SC media. Results showed that cells grown in all three media reached 
a saturation at lOng/ml. Cells grown in SF medium showed the highest uptake 
activity of 59.96 土 1.49 nmole/mg of protein at lOng/ml TNF although the 
levels fluctuated from 0 - 10 ng/ml. There is a subsequent decrease in uptake 
after lOng/ml TNF. Cells grown in S and SC media, however, reached the 
uptake activity of 13.98 土 0.92 nmole/mg of protein and 11.04 土 0.66 
nmole/mg of protein, respectively, with 20ng/ml of TNF. 
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Fig. 3.5: Dose-dependent effect of TNF on [^H]-taurine uptake in 
astrocytes cultured in three treatment media as indicated in the figure. 
Astrocytes were cultured with different concentrations of TNF for 48 hours. 
The cells were then incubated with [^H]-taurine (0.2pCi/well) at a final 
concentration of 0.3mM in 0.25ml of physiological buffer at 37°C for 40 
minutes. Values are shown as means 土 SD and each value was measured in 
triplicate. 
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3.1.4 The effects of TNF exposure time on taurine uptake 
In previous experiments, astrocytes were incubated with TNF for 48 
hours to test the effects of TNF on taurine uptake. In order to examine the 
effect of incubation time of TNF on taurine uptake, cells were incubated with 
TNF at different time point. This study may provide some clues as to the 
mechanisms whereby TNF may affect taurine uptake in astrocytes. The cells 
were incubated with 20ng/ml TNF for 4, 12, 24, 48 or 72 hours, and the 
activity of taurine uptake was determined. 
Astrocytes cultured in serum-free medium showed the highest taurine 
uptake among the three groups (Fig. 3.6). This is similar to that shown in Fig. 
3.1 where cells grown in SF medium also had the highest taurine uptake. 
Taurine uptake in astrocytes cultured in the three media was not significantly 
affected within the first 12 hours exposure to 20ng/ml of TNF (Fig. 3.6)，but 
a marked increase was observed by 24 hours incubation. For astrocytes 
cultured in serum-free medium, taurine uptake reached a maximum value of 
42.52 土 3.45 nmole/mg of protein when the cells were primed with TNF for 
48 hours (Fig. 3.6). For astrocytes cultured in serum-containing medium, the 
marked increase in taurine uptake was observed at 24 hours (11.79 土 0.86 
nmole/mg of protein) and levelled off afterwards (Fig. 3.6). For astrocytes 
cultured in serum plus dbcAMP medium, the increase in taurine uptake was 
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Fig. 3.6: Time course of TNF exposure on [^H]-taurine uptake in 
astrocytes cultured in the three treatment media. As t rocy tes were 
incubated with 20ng/ml TNF for 4, 12，24, 48 and 72 hours prior to the 
taurine uptake experiment： The cells were incubated with [^H]-taurine 
(0.2pCi/well) at a final concentration of 0.3mM in 0.25ml of physiological 
buffer for 40 minutes at 37°C. Values are shown as means 土 SD and each 
value was measured in triplicate. 
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linear with that of the time of incubation with TNF reaching 10.22 ±1.81 
nmole/mg of protein by 72 hours (Fig. 3.6). From this study, it seems that 48 
hours of exposure to 20ng/ml TNF is quite adequate to produce a stimulatory 
effect on taurine uptakes in cultured astrocytes. 
3.1.5 The effects of TNF on cell volume change in astrocytes 
Taurine is an osmoregulator in the brain, and it may be responsible for 
cell volume regulation in astrocytes (Pasantes-Morales & Schousboe, 1990). 
In order to investigate i f the TNF-induced increase in taurine uptake in 
astrocytes was not the result of the cell volume change, the effects of TNF on 
cell volume was examined. 
3-O-methyl glucose, a glucose analog which cannot be metabolized in 
the cells, was used as an index for cell volume change. 3-O-methyl glucose 
is a good cell volume marker because it is taken up into the cell with water 
until the extracellular and intracellular concentrations reached an equilibrium 
(Kimelberg & Frangakis, 1985). 
Table 3.1 showed the effects of TNF on cell volume change in 
astrocytes cultured in SF, S and SC media. TNF exposure has no significant 
effects on cell volume change in astrocytes grown in the three treatment 
media although there was a trend showing that astrocytes primed with TNF 
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Table 3.1: The effects of TNF on astrocyte cell volume change 
Culture medium TNF Cell Volume 
(20ng/ml) (pl/mg of protein) 
Serum-free Control 4.95 ± 0.59 
+ TNF 3.92 土 0.53 
Serum (10%) Control 5.54 土 0.6 
+ TNF 4.27 土 0.53 
Serum (10%) + Control 5.97 土 0.54 
dbcAMP (0.25mM) + TNF 4.09 ± 0/79 
The effects of TNF on cell volume changes on astrocytes cultured in 
SF, S and SC media. Astrocytes cultured in 24-well plate were incubated 
with 20ng/ml TNF for 48 hours. Cells were then incubated with [^H]-30MG 
(0.435mCi/well, specific activity: 5Ci/mmole) in 0.25ml physiological buffer 
(without glucose) for 10 minutes at 37°C and the media in each well were 
discarded. Cells were then solubilized with I M NaOH. The radioactivity and 
protein in each well were determined. Values are shown as means 土 SD and 
each value was measured in triplicate. 
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had smaller cell volumes than those without TNF. This result implied that the 
effects of TNF observed in the previous experiments on taurine transport were 
not due to a change in cell volume. 
3.1.6 Comparison of the effects of TNF on taurine uptake 
amongst cultured primary rat astrocytes, primary mouse 
astrocytes and C6 glioma cell line 
In this study, the effects of TNF on taurine uptake in astrocyte cultured 
from three different sources were examined. This is to establish the species 
specificity of the effects of TNF on taurine transport. Astrocytes from three 
sources were cultured in SF, S and SC media to investigate i f different culture 
media affect taurine uptake in these astrocytes. 
Table 3.2 shows the taurine uptake activity of rat and mouse cortical 
astrocytes, and C6 glioma cells cultured in SF, S and SC media. In primary 
rat astrocytes cultured in SF medium, taurine uptake (35.30 土 0.80 nmole/mg 
of protein) was the highest, which is 3.7 and 8.9 fold higher than cells grown 
in S and SC media. However, not much difference was observed in taurine 
uptake activity in mouse astrocytes cultured in the three different media. In 
C6 glioma cells, taurine uptake activity in S medium (12.97 土 0.69 nmole/mg 
of protein) was the highest, which is about 2.3 and 1.5 fold that of cells 
grown in SF and SC media, respectively. 
69 
Table 3.2: Comparison of pH]-taurine uptake in cultured astrocytes 
among rat，mouse astrocytes and C6 glioma cell line 
Taurine uptake 
(nmole/mg of protein) 
Cell source “ 
Serum (10%) 
Serum (10%) plus dbcAMP 
Serum-free containing (0.25mM) 
medium medium medium 
Rat cortical 35.30 土 0.80 9.54 士 0.08 3.98 土 0.55 
Mouse cortical 6.38 土 0.86 4.97 ± 0.88 5.88 ± 0.78 
Rat C6 glioma 5.73 土 0.34 12.97 ± 0.69 8.94 ± 0.42 
Rat and mouse cortical astrocytes plated in the density of 1 x i t f 
cells/well were cultured in 24-well plates for six days in the three treatment 
media as indicated in the table. Rat C6 glioma cells in 5 x cells/well were 
cultured for four days. Astrocytes were then incubated with [^H]-taurine 
(0.2pCi/well) at a final concentration of 0.3mM in 0.25ml/well physiological 
buffer for 40 minutes at 37°C and the [^H]-taurine uptake was determined. 
Values are shown as means 土 SD and each value was measured in triplicate. 
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These findings showed that taurine transport in primary mouse cortical 
astrocytes were not too sensitive to the three treatment media while serum 
appeared to stimulate taurine uptake in C6 glioma cells. 
The results in table 3.2 show that the degree of taurine uptake was 
different in astrocytes from three different sources and that the uptake of 
taurine was also different in normal and tumor cells. 
Unlike rat astrocytes, TNF did not show any significance effects on 
taurine uptake in mouse astrocytes and C6 glioma cells irrespective of the 
culture media employed (Fig. 3.7 and 3.8). These results suggested that the 
effects of TNF on taurine uptake may be species specific. 
3.1.7 The effects of TNF on taurine release 
To study the effects of TNF on taurine transport, its effect on taurine 
release was also examined to determine whether the effects of TNF was on 
the influx or the efflux of taurine. In this study, taurine release from 
astrocytes cultured in SF, S and SC media were compared. 
Cells were pre-incubated with [^H]-taurine (1.18pCi/well, at a final 
concentration of 0.3mM in 0.25ml of physiological buffer) at 37°C for 40 
minutes. Cells were washed twice and 0.25ml fresh physiological buffer was 
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Fig. 3.7: The effects of TNF on [^H]-taurine uptake in mouse cortical 
astrocytes. Cells were incubated with TNF (20ng/ml) for 48 hours prior to 
taurine uptake assay, and other experimental conditions were similar to those 
described in Methods (Section 2.2). Values are shown as means 土 SD and 




2 14 - r - rK - i -
cu 丁 
F I _ 
I：： I ._: 
n^  illl 
•―‘ - T N F + TNF - TNF + TNF - TNF + TNF 
SERUM-FREE SERUM SERUM + cAMP 
Fig. 3.8: The effects of TNF on [^H]-taurine uptake on rat C6 glioma cell 
line. Experimental conditions were similar to those described in the Methods 
(Section 2.2) and Fig. 3.7, Values are shown as means 土 SD and each value 
was measured in triplicate. 
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Fig. 3.9 showed the level of taurine release in astrocytes cultured in the 
three media. At 1 and 5 minutes, the rate of taurine release in astrocytes 
cultured in SC medium was higher than that of S and SF media. At 1 minute, 
taurine efflux in astrocytes cultured in SC (28.58 士 9.32%) medium was the 
highest, and cells grown in S (23.92 土 3.42%) and SF (13.57 土 0.72%) media 
were about 16.3% and 52.5% lower than that of SC medium, respectively. In 
addition, at five minutes the rate of taurine release was still in the same order. 
However, beyond ten minutes, no difference was obtained between the 
treatment of the three groups. 
Following 48 hours of priming with TNF, the rate of taurine efflux was 
slightly decreased (Fig. 3.10a,b,c). Significant difference was observed in 
TNF-primed and non-primed astrocytes cultured in serum-containing medium 
at 5 minutes, and in serum plus dbcAMP medium at 5 and 10 minutes. These 
findings suggest that TNF-priming slightly decreased the rate of taurine 
release in astrocytes, but the decrease observed cannot fully explain the 
increase in taurine uptake in cells primed with TNF. 
3.1.8 The specificity of the effects of TNF on taurine uptake 
It was shown that taurine uptake was stimulated by 20ng/ml of TNF 
in astrocytes and the greatest stimulation was observed in astrocytes cultured 
in SF medium (Fig. 3.5, 3.6). The effects of TNF on other transport systems 
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Fig. 3.9: [^H]-taurine release in astrocytes cultured in the three different 
media. Astrocytes were incubated with [^H]-taurine (1.182pCi/well, at 
a final concentration of 0.3mM in 0.25ml physiological buffer) at 3 T C for 
40 minutes. At each indicated time-point, the medium was removed and 
0.25ml fresh physiological buffer was added, and the radioactivity in the 
medium was determined. Values are shown as means 土 SD and each value 
was measured in triplicate. 
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Fig 3 10a. The effects of TNF on [^H]-taurine release in astrocytes cultured 
in serum-free medium. Experimental conditions were similar to those 
described in Fig. 3.9. Cells for TNF treatment were primed with TNF m 
20ng/ml 48 hours prior to： the experiment. Values are «hown as means 土 SD 
and each value was measured in triplicate. 
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Fig. 3.1 Ob: The effects of TNF on [^H]-taurine release in astrocytes cultured 
in serum-containing (10%) medium. Experimental conditions were similar 
to those described in Fig. 3.9. Cells for TNF treatment were primed with TNF 
(20ng/ml) 48 hours prior tathe experiment. Values are shown as means 土 SD 
and each value was measured in triplicate. * p<0.05, significant difference 
from the corresponding control by using Student's f-test. 
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Fig. 3.10c: The effects of TNF on [^H]-taurine release in astrocytes cultured 
in serum (10%) plus dbcAMP (0.25mM) medium. Experimental conditions 
were similar to those described in Fig. 3.9. Cells for TNF treatment were 
primed with TNF (20ng/ml) 48 hours before the experiment. Values are 
shown as means 土 SD and each value was measured in triplicate. * p<0.05, 
significant difference from the corresponding control by using Student's r-test! 
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were also investigated in order to establish whether the effects of TNF on 
taurine transport was unique. Since taurine uptake as well as the uptake of 
other amino acids, such as glutamate, tyrosine, is also a Na^-dependent 
process, and leucine transport is a Na^-independent process, this study would 
provide information whether TNF alters transport systems by exerting its 
effect on the movement of Na+ across the membrane. 
3.1.8.1 The effects of TNF on the uptake of amino acids and 
glucose in primary rat astrocytes 
To study the specificity of TNF on different transport systems in 
astrocytes, three amino acids: glutamate, tyrosine and leucine, and also 
glucose were chosen. In the CNS, glutamate is an excitatory amino acids, it 
is taken up by astrocytes and stored in the form of glutamine (Hertz and 
Schousboe, 1986). Controlling extracellular glutamate concentration is a 
function of astrocytes because high concentration of glutamate is neurotoxic 
to neurons and causes astrocytic swelling. Therefore, this specific transporter 
for glutamate may play a protective role in brain injury. Tyrosine is an 
aromatic amino acid and is a precursor of dopamine and norepinephrine. 
Uptake of tyrosine serves to meet the nutrition requirements, in particular in 
astrocytes and therefore, an essential transporter on astrocytes. Both the 
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uptake processes for glutamate and tyrosine are Na+-dependent (Hosli, et al” 
1986), thus the results obtained may shed light on the mechanism of action 
of TNF on taurine transport. On the other hand, the uptake of leucine is an 
exchange process (Oxender, 1972) and that the uptake of both leucine and 
glucose are not via Na+-dependent processes, so the effects of TNF on leucine 
and glucose uptake were also studied. 
To assay the transport of these substrates, astrocytes were incubated 
with various labelled amino acids or glucose for 40 minutes as described 
before. The cells were then washed twice with ice-cold physiological salt 
buffer and 0.2ml of ice-cold 7.5% TCA was added, and the labelled substrate 
taken up by astrocytes determined. The present study showed that the amount 
of labelled amino acids incorporated into proteins in 40 minutes was very low 
(results not shown), it is assumed that the amount of labelled amino acids 
measured is that taken up into the cytosol only. The results were expressed 
as mmole/mg of protein. 
Fig. 3.11 showed the uptake of glutamate in astrocytes cultured in SF, 
S and SC media. Cells grown in the SF medium without the priming of TNF 
showed the highest (610 士 8 nmole/mg of protein), whereas, those cultured 
in S (354 土 3 nmole/mg of protein) and SC (389 土 14 nmole/mg of protein) 
media without TNF had a 42% and 36% lower uptake, respectively. The trend 
of these results was similar to that of taurine uptake where glutamate uptake 
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in the cells grown in SF medium was the highest. There was a 14% decrease 
(p<0.05) in glutamate uptake in astrocytes cultured in SF medium with TNF. 
However, there were no significant changes in TNF-primed astrocytes 
cultured in the other two media. The effect of TNF on glutamate uptake was 
different from that of taurine uptake, where in the latter, TNF treatment 
increased taurine uptake in astrocytes cultured in all three media. 
Fig. 3.12 showed the uptake of tyrosine in astrocytes cultured in SF, 
S and SC media. Astrocytes cultured in serum-free medium without the 
priming of TNF showed the highest tyrosine uptake (25.95 土 1.01 nmole/mg 
of protein), which was about 2.7 fold of that in cells grown in S and SC 
media. For cells grown in media with TNF, there was a 45% (p<0.05), 31% 
(p<0.05) and 22% (p<0.05) decrease in tyrosine uptake in SF, S and SC 
media, respectively. Although both taurine, tyrosine and glutamate uptake 
processes are Na+-dependent，TNF decreased glutamate and tyrosine uptake 
but stimulated taurine uptake in cultured astrocytes. The present results also 
showed a similar trend to that of taurine and glutamate uptake where cells 
grown in SF medium showed the most marked tyrosine uptake. 
Leucine is transported, in many cells, via an exchange and not via a 
Na+-dependent system. Fig. 3.13 showed the uptake of leucine in astrocytes 
cultured in SF, S and SC media. Astrocytes grown in SF and S media without 
TNF showed similar leucine uptake activity of 5.70 土 0.51 nmole/mg of 
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Fig 3.11: The effect of TNF on [^H]-glutamate uptake in astrocytes 
cultured in serum-free (SF), serum-containing (10%) (S) and serum (10%) 
plus dbcAMP (0.25mM) (SC) media. Cells for TNF treatment were incubated 
with 20ng/ml TNF for 48 hours prior to the uptake assay. The cells were 
incubated with [^H]-glutamate (0.556pCi/well) at a final concentration of 
0.3mM in 0.25ml physiological buffer at 37。C for 40 minutes. Values are 
shown as means 土 SD and each value was measured in triplicate. * p<0.05, 
significant difference from the corresponding control by using Student's "test. 
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Fig. 3.12: The effect of TNF on [^H]-tyrosine uptake in astrocytes cultured 
in the three indicated media. Experimental conditions were similar to those 
described in Fig. 3.11，and the final concentration of tyrosine (with 
0.781pCi/well pH]-tyrosine) was 0.3mM. Values are shown as means 土 SD 
and each value was measured in triplicate. * p<0.05; significant difference 
from the corresponding control by using Student's f-test. 
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protein and 5.93 土 0.35 nmole/mg of protein, respectively. There was an 
approximately 25% decrease in leucine uptake in the cells cultured in SC 
medium (4.36 士 0.27 nmole/mg of protein) (Fig. 3.13). The trend of leucine 
uptake was not similar to that of glutamate and tyrosine uptake. In the 
presence of TNF, leucine uptake was decreased by 12%, 30% (p<0.05) and 
8% for the cells cultured in SF, S and SC media, respectively. It seems that 
the effects of TNF on substrate transport depends on the substrate studied and 
the culture conditions of astrocytes rather than the Na+-dependence of the 
transport system. 
Fig. 3.14 showed glucose uptake in astrocytes cultured in SF, S and SC 
media. Cells grown in the SF medium without the priming of TNF showed 
the highest uptake of 3.48 土 0.22 nmole/mg of protein, and 30MG uptake in 
S (1.97 土 0.23 nmole/mg of protein) and SC (2.07 土 0.08 nmole/mg of 
protein) showed a decrease by 43% and 40% respectively. Cells grown in the 
three different media with the priming of TNF, showed a 27% (p<0.05), 13% 
and 10.6% decrease for the SF, S and SC media, respectively. 
From the above, its clear that the effects of TNF on glutamate, 
tyrosine, leucine and glucose uptake in astrocytes were different from that of 
taurine uptake. TNF increases taurine uptake in cell grown in all three media, 
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Fig 3 13. The effect of TNF on [^H]4eucine uptake in astrocytes cultured 
in the three indicated media. Experimental conditions were simito to those 
described in Fig. 3.11. The final concentration of leucine (with 0.2pCi/well 
^Hl-leucine) was 0.3mM: Values are shown as means 土 SD and each value 
was measured in triplicate. * p<0.05, significant difference from the 
corresponding control by using Student's "test. 
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Fig. 3.14: The effect of TNF on glucose uptake in astrocytes cultured in 
the three indicated media. Astrocytes were cultured with 0.435)iCi/well 3-0-
methyl-[^H]-glucose at a final concentration of Qj3mM in 0.25ml of 
physiological buffer at 37^C for 40 minutes. Experimental conditions were 
similar to that described in Method (Section 2.5.2). Values are shown as 
means 土 SD and each value was measured in triplicate. * p<0.05, significant 
difference from the corresponding control by using Student's Mest. 
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three media. On the other hand, astrocytes grown in SF medium showed the 
highest glutamate, tyrosine and glucose uptake, similar to that observed in 
taurine uptake. 
3.1.8.2 The effects of TNF on neurotransmitters uptake 
Astrocytes possess transport systems for neurotransmitters, such as 
norepinephrine (NE), dopamine (DA) and 4-aminobutyric acid (GABA) which 
are important in the regulation of synaptic transmission via a glial-neuronal 
communication. The uptake of these neurotransmitters is via a Na+-dependent 
process (Kimelberg and Ransom, 1986; Hansson and Ronnback, 1991), 
similar to that of taurine uptake. The effects of TNF on these uptake systems 
were also examined so as to compare whether the increased taurine uptake by 
TNF treatment is specific. 
The procedure used for neurotransmitters uptake studies were similar 
to that described for amino acid uptake except the time of incubation was 
reduced to 20 minutes (Iversen, 1973). Also, in these experiments, appropriate 
I 
metabolic inhibitors, such as pargyline and AOAA were added to reduce the 
degradation of these neurotransmitters during incubation. 
Fig. 3.15 showed the results of DA uptake in astrocytes cultured in SF, 
S and SC media. Cells cultured in all three media without TNF showed no 
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significant differences in DA uptake. For the cells grown in the three media 
with TNF, there was only 7% and 15% increase in DA uptake in SF and SC 
media respectively, with a 6% decrease in DA uptake in the cells grown in 
S medium. In general, from the present results, TNF did not seem to have any 
significant effects on DA uptake in astrocytes. 
Fig. 3.16 showed the results of NE uptake in astrocytes cultured in SF, 
S and SC media. NE uptake was the highest in astrocytes cultured in SF 
without TNF medium (5.09 土 0.77 nmole/mg of protein), with 35% and 25% 
lower in the cells cultured in S (3.32 ±0.19 nmole/mg of protein) and SC 
(3.81 土 0.26 nmole/mg of protein) media, respectively. TNF priming did not 
cause any significant changes in NE uptake. 
Fig. 3.17 showed the results of GABA uptake in astrocytes cultured in 
SF, S and SC media, GABA uptake was the highest in astrocytes cultured in 
SF medium (14.4 ±1.7 nmole/mg of protein), with 14% and 13% lower in 
the cells cultured in S (12.4 土 1.1 nmole/mg of protein) and SC (12.6 土 1.4 
nmole/mg of protein) media, respectively. Cells grown in the three media with 
the addition of TNF showed a 12% (12.7 土 0.2 nmole/mg of protein), 14% 
(10.7 土 0.3 nmole/mg of protein, p<0.05) and 22% (9.73 士 0.58 nmole/mg of 
protein, p<0.05) decrease in GABA uptake. 
The present results showed that NE and GABA uptake was highest in 
cell grown in SF medium. DA uptake was not significantly different in cells 
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Fig. 3.15: The effects of TNF on [^H]-dopamine uptake in astrocytes 
cultured in the three treatment media. Astrocytes were incubated with 
0.143pCi/well [^H]-dopamine at a final concentration of 0.3mM in 0.25ml of 
physiological buffer in thre presence of pargyline ( ImM) at 37°C for 20 
minutes. Cells for TNF treatment were incubated with TNF in 20ng/ml 48 
hours prior to the uptake experiment. Values are shown as means 土 SD and 
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Fig. 3.16: The effect of TNF on norepinephrine uptake in astrocytes 
cultured in three indicated media. Experimental conditions were similar 
to those described in Fig. 3.15. Astrocytes were cultured with 0.182pCi/well 
[^Hl-norepinephrine at a final concentration of 0.3mM in 0.25ml of 
physiological buffer in the presence of pargyline ( ImM) at 37。C for 20 
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Fig. 3.17: The effect of TNF on GAB A uptake in astrocytes cultured in 
various media. Experimental conditions were similar to those described 
in Fig. 3.15. Astrocyte were incubated with 0.227pCi/well [^H]-GABA at a 
final concentration of 0.3mM in 0.25ml of physiological buffer in the 
presence of AOAA (0.03mM) at 3TC for 20 minutes.' Values are shown as 
means 土 SD and each value was measured in triplicate. * p<0.05, significant 
difference from the corresponding control by using Student's Mest. 
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grown in the three different media. The addition of TNF in the culture media 
did not significantly alter the uptake of DA and NE, but decreased GABA 
uptake in the cells cultured in S and SC media. This suggests that the effects 
of TNF on taurine uptake is a specific as it is the only transport system that 
was stimulated. Furthermore, although the uptake of taurine, DA, NE and 
GABA (Hosli et al., 1986) were all Na+-dependent processes, TNF only 
stimulated the uptake of taurine, but not of the neurotransmitters. This may 
imply that TNF exerts it stimulation of taurine uptake (Fig. 3.2a，b，c) not by 
altering the Na+ movement across the plasma membrane. 
3.1.9 The effects of LPS on taurine uptake in astrocytes 
Since other inflammatory agents, such as lipopolysaccharides (LPS) 
have been shown to induce TNF secretion in astrocytes (Chung and 
Benveniste, 1990), it is logical to examine whether LPS has any effect on 
taurine uptake in astrocytes. 
Astrocytes were incubated with LPS in concentrations of 1，10 and 
lOOng/ml 48 hours prior to the taurine uptake experiment. This incubation 
period is sufficient for LPS to induce TNF secretion from astrocytes (Chung 
and Benveniste, 1990). 
For astrocytes cultured in serum-free medium, taurine uptake was 
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increased by 24% when the cells were primed with Ing/ml of LPS (29.3 土 1.5 
nmole/mg of protein) (Fig. 3.18). However, there was no further increase in 
taurine uptake when the concentration of LPS was increased to lOng/ml and 
at lOOng/ml of LPS, taurine uptake was increased to 32.2 ±3.7 nmole/mg of 
protein (p<0.05). 
For cells cultured in serum-containing medium as shown in Fig. 3.19, 
there was a concentration-dependent increase in taurine uptake. At Ing/ml of 
LPS (9.86 土 0.81 nmole/mg of protein), there was a 45% increase in taurine 
uptake, however, no significant differences were observed between the cells 
treated with lOng/ml and lOOng/ml of LPS. Although TNF was not 
determined in these experiments, it is likely that LPS exerted its effect on 
taurine transport by inducing the secretion of TNF as previous studied have 
shown that 18 hours exposure to LPS is sufficient to induce TNF secretion 
from astrocytes (Chung and Benveniste, 1990). 
In contrast, LPS at the range of 1 to lOOng/ml did not stimulate taurine 
uptake in astrocytes cultured in serum plus dbcAMP medium (Fig. 3.20). 
These results may imply that LPS failed to induce TNF secretion from mature 
astrocytes. I f this is true, it would indicated that astrocytes in different 
maturation states respond differently to inflammatory signals, such as LPS. 
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Fig. 3.18: The effect of LPS on taurine uptake in astrocytes cultured in 
serum-free medium. Astrocytes were cultured with LPS in different 
concentrations as indicated in the figure 48 hours prior to taurine uptake 
assay. Experimental conditions of taurine uptake were same to the Method 
(Section 2.2). Values are shown as means 土 l§D and each value was measured 
in triplicate. * p<0.05, significant difference from that of 0 ng/ml of LPS by 
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Fig. 3.19: The effect of LPS on taurine uptake in astrocytes cultured in 
serum-containing (10%) medium. Experimental conditions were similar to 
those described in Fig. 3.18 and in the Method (Section 2.2). Values are 
shown as means 土 SD an^ each value was measured in triplicate. * p<0.05, 
significant difference from that of 0 ng/ml LPS by using Student's r-test. 
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Fig 3 20. The effect of LPS on taurine uptake in astrocytes cultured in 
• serum (10%) plus dbcAMP (0.25mM) medium. Experimental conditions were 
similar to those described in Fig. 3.18. Values are shown as means 土 SD and 
each value was measured in triplicate. , 
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3.1.10 The effects of IFN-x on taurine uptake in astrocytes 
Apart from TNF, IFN-x was also examined to test its effect on taurine 
uptake in astrocytes as IFN-T can induce immune responses on astrocytes 
which are similar to that of TNF. Fig. 3.21 showed the effects of mouse 
recombinant IFN-T on taurine uptake in astrocytes cultured in S F , S and S C 
media. Cells were incubated with either TNF or IFN-T or with both. Controls 
are cells growth without any T N F or IFN-T. The taurine uptake in the 
presence of TNF was included for comparison. With the priming of IFN-x 
(500U/ml), taurine uptake was decreased by 29%, 30% and 17% in the cells 
grown in SF (25.2 土 3.9 nmole/mg of protein, p<0.05), S (6.70 土 0.34 
nmole/mg of protein, p<0.05) and SC (3.31 土 0.18 nmole/mg of protein), 
respectively. 
Although IFN-T was shown to decrease taurine uptake, but this effect 
was reversed by the addition of TNF (20ng/ml) in cells cultured in S and SC 
media, while no significant difference was observed in cells cultured in SF 
medium. Compare the results obtained with IFN-x, the further addition of 
TNF, taurine uptake was increased by about 2 fold in IFN-x primed astrocytes 
grown in S (12.6 土 1.1 nmole/mg of protein, p<0.05) and SC (6.52 土 0.35 
nmole/mg of protein, p<0.05) media, respectively. These results suggest that 
these two cytokines acted differently on taurine transport in astrocytes, being 
stimulatory in the presence of TNF but inhibitory in the presence of IFN-T. 
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Fig. 3.21: The effect of IFN-T on taurine uptake in astrocytes cultured in 
three treatment media. Astrocytes were cultured in three treatment media 
for six days. Astrocytes were incubated with either 500U/ml IFN-t (I), 
20ng/ml TNF (T) or IFN-T and T N F (I+T) for 48 hours prior to the taurine 
uptake assay. Control cells received no cytokine treatment (C). The 
procedures of this assay were the same as those described in Section 2.2.1. 
Values are shown as means. 土 SD and each value was measured in triplicate. 
* p<0.05, significant difference from the corresponding control by using 
Student's Mest. 
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The findings further showed that taurine uptake in astrocytes is stimulated 
specifically by TNF. 
3.2.7 The effects of PMA on taurine uptake 
At present, taurine uptake was shown to be stimulated by TNF, and the 
mechanism of TNF stimulation on taurine uptake need to be further studied. 
As protein kinase C (PKC) was shown to be involved in the signalling 
pathways in lymphocytic, monocytic and erythroid cells (Schiitze et al., 1990)， 
and PKC was shown to stimulate taurine release in U373-MG astrocytoma 
cells (Lee et al., 1992), phorbol 12-myristate-13-acetate (PMA), a protein 
kinase C (PKC) activator, was used to study whether PKC has any effect on 
taurine uptake in rat astrocytes. 
Fig. 3.22 showed the effects of PMA on taurine uptake in astrocytes 
cultured in SF, S and SC media. Astrocytes cultured in SF media showed a 
decrease in taurine uptake when incubated with 5pM (from 23.6 ± 1 . 8 
nmole/mg of protein to 14.3 土 0.6 nmole/mg, p<0.05) and lOpM PMA (to 
13.0 土 1.7 nmole/mg of protein, p<0.05). Cells cultured with S medium 
showed only 36.4% and 12% increase in taurine uptake with 5pM and lOpM 
PMA (from 6.8 土 0.7 nmole/mg of protein to 9.3 士 0.8 nmole/mg of protein 
and 7.6 土 0.7 nmole/mg of protein, p<0.05), respectively. The results showed 
that the differences at 5pM and lOpM PMA on taurine uptakes in astrocytes 
99 
cultured in SC medium was negligible. The effects of PMA on taurine uptake 
is however different to that of TNF where TNF stimulated taurine uptake in 
astrocytes cultured in the three media. 
Apart from PKC activator, PKC inhibitor should be tried in future to 
further prove that the mechanisms whereby TNF exerts its effect on taurine 
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Fig. 3.22: The effects of PMA on taurine uptake in astrocytes cultured in 
various media. Cells were cultured with PMA in the final concentration of 
5pM or lOpM for 24 hours before the assay. The procedures of taurine uptake 
assay were same to those described in Section 2.2.1 .‘Values are shown as 
means 土 SD and each value was measured in triplicate. * p<0.05, significant 
difference from the corresponding control by using Student's Mest. 
101 
3.2 The effects of TNF on cell metabolism in rat astrocytes 
In order to examine some of the intracellular effects of TNF, firstly, the 
effects of TNF on cell proliferation, RNA synthesis and protein synthesis 
were studied. Secondly, the effects of TNF on second messenger, such as 
cGMP level, protein phosphorylation and calcium uptake were also examined. 
The results in this section may provide ideas of how TNF affected taurine 
uptake. 
3.2.1 The effects of TNF on astrocyte proliferation 
TNF has been shown to increase bovine and human astrocytes 
proliferation (Barna et al., 1990, Selmaj et al., 1988). The proliferative effects 
of TNF on rat cortical cultured astrocytes was also examined. Astrocytes in 
cell density of 1 X lO^ cells/ml were cultured in 96-well plate for seven days. 
48 hours prior to the thymidine incorporation, astrocytes were pre-incubated 
with 20ng/ml TNF, then incubated with 2pCi/well [^H]-thymidine for 20 hours 
and the level of cell proliferation was measured in terms of [^H]-thymidine 
incorporation into DNA. 
Fig. 3.23 showed the level of [^H]-thymidine incorporation in 
astrocytes cultured in SF, S and SC media. [^H]-thymidine incorporation was 
found to be the lowest in astrocytes cultured in SF (1180 ± 103 cpm) medium 
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without TNF, with a 40% and 56% increase in the cells cultured in S (1650 
土 264 cpm) and SC (1840 土 156 cpm) media, respectively. 
[^H]-thymidine incorporation was significantly increased (p<0.05) in 
astrocytes cultured in all three media when exposed to 20ng/ml TNF. This 
increase was about 50% (SF), 40% (S) and 28% (SC) higher than that of the 
corresponding control. 
The present results showed that TNF stimulates rat astrocyte 
proliferation like those of bovine and human (Bama et al., 1990，Selmaj et al., 
1988) and that the proliferation is highest in cells grown in SC media 
suggesting that astrocytes which are more differentiated showed a greater 
degree of proliferative activity. 
3.2.2 The effects of TNF on RNA synthesis 
Fig. 3.24 showed the levels of [^H]-uridine incorporation in astrocytes 
cultured in SF, S and SC media. Results showed that [^H]-uridine 
incorporation was the lowest in cells grown in SC medium without TNF 
(2695 土 128 cpm/well), when compare to cells grown in SF (3513 士 464 
cpm/well) and S (3735 ±176 cpm/well) media. 
In TNF-primed astrocytes, the levels of [^H]-uridine incorporation was 
increased by over 100% and 45.2% (p<0.05) in astrocytes cultured in SF 
103 
% ^ 3000 
g • p<0.05 
Pi 
a 2 5 0 0 一 J* T * “ o , ,1 , , 5 rTTi Pffl cd u 
^ 2 0 0 0 - * 丁 = = = -
o T T ~ " " 
• 
HJ i __ 
i l lMi l l 
- T N F +TNF - T N F +TNF - T N F +TNF 
S e r u m - F r e e S e r u m S e r u m + d b c A M P 
Fig. 3.23: The effects of TNF on [^H]-thymidine incorporation in 
astrocytes cultured in serum-free (SF), serum-containing (10%) (S) and serum 
(10%) plus dbcAMP (0.25mM) (SC) media. Cells were cultured in 96-well 
plates in a plating density (tf 1 x 10' cells/ml for six days. For TNF treatment, 
TNF was added 48 hours before harvesting. Astrocytes were incubated with 
2pCi/well [^H]-thymidine for 20 hours before harvesting. Values are shown 
as means 土 SD and each value was measured from six separate wells: * 
p<0.05, significant difference from the corresponding control by using 
Student's Mest. 
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Fig. 3.24: The effect of TNF on [^H]-uridine incorporation in astrocytes 
cultured in three treatment media. Experimental conditions were similar to 
that described in Fig. 3.23. Astrocytes were incubated with 2pCi/well [^H]-
uridine for 20 hours before harvesting. Values are shown as means 土 SD and 
each value was measured from six separate wells. * p<0.05, significant 
difference from the corresponding control by using Student's Mest. 
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(7286 土 632 cpm/well) and SC (3913 土 241 cpm/well) media, respectively. 
However, no significant change was observed for TNF-primed astrocytes 
grown in S medium. The present results showed that TNF stimulates RNA 
synthesis in both astrocytes cultured in SF and SC media. 
3.2.3 The effects of TNF on protein synthesis 
[^H]-leucine was used to assess protein synthesis because leucine is a 
ketogenic amino acid and is not metabolised to a great extent. In this study, 
astrocytes were incubated with [^H]-leucine for 20 hours, and the radioactivity 
in the TCA precipitate was measured to assess [^H]-leucine incorporation. 
Fig. 3.25 shows the results of [^H]-leucine incorporation in astrocytes 
cultured in SF, S and SC media. Cells cultured in SC medium without TNF 
showed the highest level of [^H]-leucine incorporation (7102 土 820 cpm/well), 
with a 17% and 37% decrease in cells cultured in S and SF media, 
respectively. 
In TNF-primed astrocytes, there was a slight but significant increase 
in [3H]-leucine incorporation in cells cultured in SF medium (5151 士 219 
cpm, p<0.05). Cells grown in SC and S media showed no significant changes 
in [^H]-leucine incorporation upon TNF exposure. 
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Fig. 3.25: The effect of TNF on [^H]-leucine incorporation in astrocytes 
cultured in three treatment media. Experimental conditions were similar to 
that described in Fig. 3.23. Astrocytes were incubated with 2pCi/well [^H]-
leucine for 20 hours before harvesting. Values are shown as means 土 SD and 
each value was measured from six separate wells. * p<0.05, significant 
difference from the corresponding control by using Student's r-test. 
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3.2.4 The effects of TNF on basal level of cGMP 
� 
Although TNF is not known to affect cGMP levels in astrocytes, its act 
on cGMP was assessed as natriuretic peptides have been shown to stimulate 
cGMP production in mouse astrocytes (Yeung et al., 1991，1992a，b). 
Fig. 3.26 showed the basal levels of cGMP in astrocytes cultured in 
SF, S and SC media. Cells grown in SF medium without TNF had the highest 
(16.82 土 1.60 pmole/mg of protein) level of cGMP, with cell grown in S 
(2.79 士 0.22 pmole/mg of protein) and SC (4.88 土 0.43 pmole/mg of protein) 
media being 83% and 71% lower, respectively. 
cGMP level was decreased by 60% in TNF-primed astrocytes grown 
in SF medium (6.65 土 0.84 pmole/mg of protein, p<0.05), whereas cGMP 
levels was increased by 1.36 and 3.24 fold in astrocytes cultured in S (3,80 
士 0.18 pmole/mg of protein, p<0.05) and SC (15.85 土 0.59 pmole/mg of 
protein, p<0.05) media respectively. The effects of TNF on cGMP levels vary 
markedly between cells grown in SF and SC medium. This suggested that the 
effects of TNF on cGMP production depend on the maturation state of the 
astrocytes. Due to the large stimulatory effects of TNF on astrocytes grown 
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Fig. 3.26: Priming effect of TNF on basal level of cGMP in astrocytes 
cultured in SF, S and SC media. Cells were cultured in six-well plates in the 
density of 1 x 10^  cells/ml for six days. Astrocytes for TNF treatment were 
incubated with TNF in 20ng/ml 48 hours prior to the assay. cGMP level was 
determined according to the procedures in the cGMP assay kit. Values are 
shown as means 土 SD and each value was measured in triplicate. * p<0.05, 
significant difference from the corresponding control by using Student's r-test. 
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Fig. 3.27: Dose-dependent effect of TNF on basal level of CGMP in 
astrocytes cultured in serum (10%) plus dbcAMP (0.25mM) medium. Cells 
were cultured in six-well plates for six days. The level of cGMP was 
determined according to the procedure in the Amersham cGMP assay kit. 
Values are shown as means 土 SD and each value was measured in triplicate. 
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Fig. 3.27 showed the basal levels of cGMP in astrocytes cultured in SC 
medium incubated with 5，10, 20 and 30ng/ml of TNF. The level of cGMP 
in astrocytes primed with 20 ng/ml TNF had the highest (15.85 土 0.59 
pmole/mg of protein, p<0.05), which was about 3.3 fold that of the control. 
At 30ng/ml of TNF, cGMP level was decreased to (8.40 土 0.44 pmole/mg of 
protein) suggesting that 20ng/ml of TNF gives the maximum effect in 
stimulating cGMP production. 
3.2.5 The effects of TNF on protein phosphorylation 
Since TNF was shown to affect protein phosphorylation in U937 
monocyte cell line (Schutze et al., 1989)，the effect of TNF on protein 
phosphorylation was studied. 
Fig. 3.28 showed the pattern of protein phosphorylation in astrocytes 
cultured in S and SC media. Results for astrocytes cultured in SF medium 
were not shown since no protein phosphorylation was detected. Protein 
phosphorylation at the molecular weight of about 16Kd was slightly inhibited 
(compare lanes 4 and 5) in astrocytes cultured in S medium; with the priming 
and the incubation with TNF, further inhibition of phosphorylation of the 
16Kd protein(s) (compare lanes 4 and 5). Unlike cells grown in the S 
medium, protein phosphorylation occurred in serveral protein bands (lane 3). 
The 16Kd band was stimulated in astrocytes cultured in SC medium primed 
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Fig. 3.28: The effects of TNF on protein phosphorylation in astrocytes 
cultured in S and SC media. Astrocytes were cultured in this two treatment 
medium with a density of 1 x 10^ cells/ml for six days. Cells were not primed 
with TNF (lane 3,4), primed with TNF (lane 2,5), and with further incubated 
with TNF (lane 1,6). Ip l pPJ-ATP (0.333pmole/tube, IpCi/tube) was added 
to 20pl sample at 37°C for 5 minutes. The sample was applied to 12.5% SDS-
PAGE minigel system. The sample were run at constant current of 40mA and 
at a voltage of 150V for one and a half hour. The gel was then covered with 




with TNF (compare lanes 3 and 2), however, i f the cells were further 
incubated with TNF for 10 minutes phosphorylation of this band was decrease 
(comparing lanes 1 and 2). On the other hand, comparsion of the bands at the 
positions of about 25Kd, 50Kd and 90Kd in astrocytes grown in S and SC 
media, little relatively phosphorylation occurred in the cells cultured in S 
medium when compare with those in SC medium. These results showed that 
astrocytes cultured in the three media have different responses to TNF in 
protein phosphorylation. 
3.2.6 The effects of TNF on calcium uptake 
Since TNF has been shown to increase Ca^^  ion channel density in rat 
superior cervical ganglia (Soliven and Julyan, 1992) and Ca^^ is known to 
affect taurine release (Dutton and Philibert, 1990)，the effect of TNF on ^ ^Ca^ ^ 
uptake in astrocytes was studied. 
Fig. 3.29 shows the effects of TNF on calcium uptake in astrocytes 
cultured in SF, S and SC media. Calcium uptake in astrocytes cultured in SF 
medium without TNF was the highest (0.81 ±0.10 pM/mg of protein), with 
46% and 48% decrease in the cells grown in S (0.44 土 0.05 pM/mg of 
protein) and SC (0.42 土 0.06 pM/mg of protein) media. Cells primed with 
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Fig. 3.29: The effect of TNF on calcium uptake in astrocytes cultured in 
the three treatment media. Astrocytes were cultured with 20ng/nil TNF for 
48 hours prior to the experiment. The cells were incubated with "^ C^a^ "^  in 
lOpCi/ml for 5 minutes in 0.25ml MCDB medium (0.03mM Ca^^) at 37°C 
water bath. Values are shown as means 土 SD and each value was measured 
in triplicate. * p<0.05, significant difference from the corresponding control 
by using Student's f test. 
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SF medium. In contrast, Ca^^  uptake in astrocytes cultured in SC medium was 
increased by 24% with no change was observed in the cells grown in S 
I . ‘ 
medium. These results showed that immature astrocytes have a higher calcium 
uptake capability and TNF has a significant effect in decreasing this uptake. 
% 
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Discussion and Conclusion 
Chapter IV DISCUSSION AND CONCLUSION 
Cell volume and osmotic changes are often associated with brain 
injury or brain inflammation. Astrocytes are the most important cells to 
restore the normal osmolarity in the brain by manipulating the uptake and/or 
efflux of osmolytes, e.g. taurine. In addition, the breakdown of the BBB in 
brain injury wi l l induce certain immune responses in the brain through the 
effects of cytokines and their interactions with astrocytes, antigen-presenting 
cells, and lymphocytes. TNF is one of the cytokines which is secreted by 
lymphocytes or astrocytes and can amplify the immune response in the 
brain, yet little is yet known about its neuromodulatory function other than 
the immunological role in the CNS. 
In certain neuropathological states, such as brain injuries and acute 
encephalomyelitis, astrocytic swelling is an early event in response to 
changes of osmolarity in the brain (Kimelberg & Ramson, 1986). Taurine 
is an important osmolyte in both astrocytes and neurons, and that its uptake 
and release activity are the adaptive responses to the changes in osmolarity, 
it is therefore important to investigate the relationship between TNF and 
taurine transport in astrocytes. The major aims of this study are to examine 
the effects of TNF on taurine transport system in cultured rat astrocytes and 
to examine whether it plays a neuromodulatory role in the brain. 
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In the present study, taurine transport in astrocytes cultured in three 
defined media which allows cells grown to different differentiation states to 
be investigated throughout this study. Astrocytes cultured in serum-free (SF) 
medium represent undifferentiated astrocytes, whereas those cultured in 
serum plus dbcAMP (SC) medium provide differentiated and matured star 
shape astrocytes (Fischer et al” 1982; Weibel et al., 1984; Tardy et al., 
1991). Astrocytes cultured in serum-containing medium (S) are considered 
to be cells undergoing natural growth. 
In order to study the influence of TNF on taurine transport, the 
effects of various concentrations of TNF and various exposure times, the 
effect of TNF on kinetic parameters, such as K^ and V隨 of the taurine 
transport system, also were investigated. In addition, the effect of TNF on 
other transport systems like amino acids, neurotransmitters and glucose were 
examined in order to establish whether the effect of TNF on taurine uptake 
is a substrate-specific. Since TNF secretion can be induced by LPS (Chung 
and Benveniste, 1990)，its effect and that of IFN-x, another cytokine found 
in the CNS, on taurine uptake were examined to further study the specific 
actions of TNF. In order to gain some insights into the mechanism of action 
of TNF on taurine transport and other metabolic processes, the effects of 
TNF on DNA, RNA and protein synthesis as well as its effect on cGMP 
production, Ca!. uptake and protein phosphorylation were also included in 
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the present study. 
The results obtained showed that taurine uptake in astrocytes is a 
saturable and time-dependent process. Taurine transport in astrocytes 
cultured in different media showed some variations, being many fold higher 
in the cells grown in the SF medium. It appears that serum may decrease the 
uptake of taurine as taurine uptake in serum-containing (S) and serum plus 
dbcAMP (SC) media are reduced (Table 3.2). However, the presence of 
serum in the culture media appears to stimulate taurine uptake in rat C6 
glioma cells as taurine uptake in serum-containing and serum plus dbcAMP 
media was 2 to 1.5 times higher than that of astrocytes cultured in SF 
medium (Fig. 3.8). On the other hand, the presence of serum in the culture 
does not significantly affect the taurine uptake in mouse cortical astrocytes 
(Fig. 3.7). This finding suggests that different culture media affects taurine 
uptake differently and that taurine uptake activity differs in different types 
of astrocytes. Species difference in K+-homeostasis and K+-evoked swelling 
have been demonstrated in mouse and rat astrocytes (Walz, 1989，1992). 
Taurine uptake in astrocytes cultured in SF medium was the highest, 
followed by cells grown in S and SC media (Fig. 3.1)，which suggests that 
immature astrocytes have much higher taurine uptake activity. In this 
connection, i t is interesting to note that the brains of newborn animals have 
a higher concentration of taurine (Sturman, 1993). Since the serum in the 
culture medium contains an appreciable amount of taurine (Wu, 1984)，this 
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may explain why astrocytes grown in SF medium when exposed to taurine 
took up taurine to a greater extent. 
Tumor necrosis factor (TNF) markedly stimulates taurine uptake in 
rat astrocytes, especially in cells cultured in S and SC media (Fig. 3.2a,b,c), 
but has only slight effect on taurine transport in mouse astrocytes (Fig. 3.7) 
and C6 glioma cells (Fig. 3.8) regardless of the culturing conditions. These 
results may be due to the fact that astrocytes from different sources 
responded to TNF differently. This dosage effect of TNF on taurine uptake 
(Fig. 3.5) is similar to the other effects of TNF, such as MHC and ICAM-1 
expression of TNF on astrocytes and brain endothelial cells where TNF 
increases their expression (Hughes et al., 1988; Vidovic et al., 1990). 
20ng/ml of TNF used in the present study appears to give the optimal 
stimulation of taurine uptake (Fig. 3.5). Also, 48 hours of exposure to TNF 
prior to taurine uptake study is quite adequate to produce the optimal effect 
of TNF on taurine uptake in rat astrocytes (Fig. 3.6). This stimulatory effect 
is not due to the action of TNF on cell volume increase as TNF did not 
significantly affect 3-0-methyl glucose accumulation. In fact, TNF pre-
incubation caused a slight decrease in cell volume (Table 3.1). The 3-0-
methyl glucose uptake technique has been used as an index to monitor cell 
volume changes in astrocytes (Kimelberg & Frangakis, 1985). 
TNF treatment did not affect the V^^^ of taurine uptake in astrocytes 
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cultured in S and SF media, except that of the astrocytes cultured in SC 
medium which is increased by 36.5%. On the other hand, the K^ values of 
the taurine transport system were decreased upon the addition of TNF, the 
most obvious decrease was obtained in astrocytes cultured in SC and SF 
media with a 68% and 70% decrease, respectively. 
The stimulated taurine uptake observed in rat astrocytes cannot be 
satisfactorily explained by the effect of TNF on taurine release as TNF 
priming only slightly inhibited the rate of taurine release. Thus, i t seems 
likely that TNF exerts its stimulatory effect on taurine transport mainly by 
modulation of taurine transporters but it may also alter the permeability of 
astrocytic plasma membrane. 
The stimulatory effects of TNF on taurine uptake is further supported 
by the observation that LPS, an inflammatory signal which can induce TNF 
secretion from astrocytes, stimulated taurine uptake in a dose-dependent 
manner (Figs. 3.18，3.19). Taurine uptake in astrocytes grown in the three 
media seems to be affected by LPS differently as taurine uptake in matured 
star shape astrocytes was not significantly affected by LPS. At present, it is 
not clear that the lack of effect of LPS on cells grown in SC medium is due 
to the failure of LPS to induce TNF release from these cells. 
Although TNF stimulated taurine uptake in cultured rat astrocytes, 
IFN-T, another cytokine found in the CNS , significantly decreased this 
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uptake activity (Fig. 3.21). With the addition of TNF to IFN-x-primed 
astrocytes, taurine uptake activity was reversed to that of control levels in 
the cells grown in S and SC media. This experiment further demonstrates 
that taurine uptake is specifically stimulated by TNF and suggests that the 
effect of TNF on taurine uptake is cytokine specific. 
As PKC activation is one of the signalling pathways which mediates 
the effects of TNF (Schiitze et al” 1990), the action of PMA, a PKC 
activator, on taurine uptake was tested. Taurine uptake was increased in cells 
grown in S and SC media but decreased in astrocytes cultured in SF 
medium (Fig. 3.22). The latter observation is not in line with the action of 
TNF as TNF stimulated taurine uptake in astrocytes cultured in all three 
media tested (Figs. 3.2a,b,c). Although taurine uptake in astrocytes grown 
in S and SC media was slightly increased by the addition of 5pM PMA, 
their activities were decreased when the PMA concentration was increased 
to lOpM. As TNF stimulated taurine uptake in astrocytes grown in all three 
media, the results suggest that activation of PKC may not be closely related 
to the stimulatory effect of TNF on taurine uptake. 
From the results in Section 3.1.8, it is clear that TNF decreased the 
uptake of amino acids (glutamate, tyrosine, leucine) as well as that of 
glucose in astrocytes grown in SF, S and SC media (Figs. 3.11, 3.12, 3.13， 
3.14). The addition of TNF caused no significant changes in 
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neurotransmitters (DA, NE, GABA) uptake in cells grown in these three 
media (Figs. 3.15, 3.16, 3.17). This effect of TNF was in contrast to that 
observed with taurine uptake where TNF stimulated taurine uptake. This 
suggests that the effect of TNF on taurine transport in rat astrocytes is 
substrate-specific. In addition, since the uptake of taurine, glutamate, 
tyrosine and the neurotransmitters tested in rat astrocytes, had been shown 
to be a Na+-dependent process, the lack of effect of TNF on other Na+-
dependent uptake processes suggest that TNF alters the activities of these 
transport systems not by interfering with the movement of Na+ across the 
astrocytic membrane. 
The finding that cells grown in SF showed the highest uptake activity 
for glutamate, tyrosine, glucose as well as for some neurotransmitters (NE, 
GABA), suggests that rat astrocytes in a relatively immature state have a 
more active substrate uptake capability than those in a more matured state. 
In the present study, the effects of TNF on other metabolic processes 
in astrocytes were also examined in order to gain some insights into the 
mode of action of TNF on taurine transport and other metabolic processes 
in rat astrocytes. TNF was shown to stimulate [^H]-thymidine incorporation 
in astrocytes grown in the three media (Fig. 3.23) implying that TNF also 
acts as a mitogen in rat astrocytes like its action in bovine and human 
astrocytes (Barna et al., 1990). Secondly, RNA synthesis was only 
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stimulated in TNF-primed astrocytes grown in SF and SC media, but protein 
synthesis was not affected by TNF except the cells cultured in SF medium. 
The reason for this differential actions of TNF is unclear at present. 
However, it seems reasonable to conclude that the stimulatory effect of TNF 
on taurine uptake in rat astrocytes may not be related to DNA，RNA and 
protein synthesis. 
TNF reduced Ca2+ uptake in cells cultured in the SF medium but had 
no effect on calcium uptake in cells grown in the other two media. (Fig. 
3.29) Although calcium ions participate in various cellular transport systems, 
i t is unlikely that TNF altered taurine uptake by interfering with Ca^^ 
movement. 
While there is no evidence to suggest that cGMP is a second 
messenger of TNF in astrocytes, recent reports on natriuretic peptides 
stimulated cGMP production in mouse astrocytes (Yeung et al.’ 1991， 
1992a，b) led to the investigation of the effects of TNF on basal level of 
cGMP in rat astrocytes. In the absence of TNF, cGMP production was 
highest in cells grown in SF medium but significantly increased cGMP 
production in cells cultured in the SC medium. Comparing the effects of 
TNF on taurine uptake (Figs. 3.2a,b,c) and basal level of cGMP (Fig. 3.26), 
it is unlikely that the effect of TNF on taurine uptake is mediated by cGMP. 
However, the effect of TNF on basal level of cGMP in astrocytes cultured 
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in the SC medium is dosage-dependent (Fig. 3.27), it may be that cGMP is 
an important second messenger of TNF in rat astrocytes. 
Protein phosphorylation is a known metabolic process of TNF in 
other cells (Schutze et al., 1989). The present finding showed that protein 
phosphorylation is very low in cells cultured in SF medium but increased 
greatly as the cells are differentiated and matured (Fig. 3.28), suggesting that 
protein phosphorylation is a more important regulatory mechanism in 
matured and differentiated astrocytes. Although the effect of TNF on the 
phosphorylation patterns of the cells grown in S and SC media cannot be 
interpreted meaningfully at present, it can be assumed that the effect of TNF 
on taurine uptake is not related to protein phosphorylation simply because 
the effect of TNF on these two parameters are very different. 
In conclusion, this study reveals that the effect of TNF on taurine 
transport in cultured rat cortical astrocytes is substrate-, species- and perhaps 
cytokine-specific. Astrocytic swelling is a strategy to rescue neurons from 
further damage in brain injuries and that TNF is one of the important 
cytokines secreted to modulate central immune responses in pathological 
conditions. The present finding showed that TNF affects the transport by 
taurine, an important central osmolyte, suggesting that the regulation of 
taurine transport by TNF may play an important neuromodulatory role in 
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